hg_58575.1

Basic information about the TSS

---

TSS ID: hg_58575.1 Species: human Chr: chr5		Start: 134371561 End: 134371579 Strand: +
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: BC005979 Distance: 0 GeneID: 7320 HGNC/MGI_ID: HGNC:12473 UniProt_ID:

Gene_name: ubiquitin conjugating enzyme E2 B Gene_symbol: UBE2B Gene_synonyms: HHR6B RAD6B UBC2 Gene_source: HGNC:12473

TATA-Box annotation

---

Distance to TSS:	394
Nearest PromoterID:	NM_003337
Entrez ID:	7320
Nearest Unigene:	Hs.612096
Nearest Refseq:	NM_003337
Nearest Ensembl:	ENSG00000119048
Gene Name:	ubiquitin conjugating enzyme E2 B
Gene Alias:	E2-17kDa
Gene Description:	ubiquitin conjugating enzyme E2 B
Gene Type:	protein-coding
CpG%:	0.14
GC%:	0.706468
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@UBE2B p2@UBE2B p3@UBE2B p4@UBE2B p5@UBE2B
Sample		p1@UBE2B	p2@UBE2B	p3@UBE2B	p4@UBE2B	p5@UBE2B
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	28.05	10.13	10.32	1.95	1.56
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	29.34	10.12	7.89	2.43	1.62
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	31.83	10.22	10.80	2.31	2.12
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	26.82	11.23	9.56	2.91	1.25
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	25.42	10.12	9.00	2.02	1.57
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	22.29	5.62	7.56	3.10	0.97
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	33.99	10.89	8.06	5.66	2.61
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	31.00	14.05	9.45	3.15	1.21
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	31.42	13.68	6.84	4.92	0.64
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	42.31	10.43	17.39	8.11	2.32
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	27.89	10.11	16.98	2.02	1.21
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	34.96	11.79	13.01	4.47	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	11.44	10.96	3.06	1.13	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	8.27	8.72	1.20	1.20	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	13.61	10.54	1.76	1.54	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	12.07	10.81	0.25	2.51	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	8.30	8.30	2.84	1.09	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	13.50	7.59	0.42	1.69	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	13.33	9.60	1.60	2.67	1.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	13.69	10.38	3.01	2.56	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	12.03	10.02	2.81	1.60	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	13.64	14.33	1.21	1.90	0.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	9.05	11.25	2.33	1.94	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	9.71	8.98	2.67	2.43	1.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	15.22	12.90	3.61	0.77	1.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	13.93	6.01	2.53	1.58	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	15.38	8.24	3.30	1.65	2.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	15.80	15.56	5.66	1.18	1.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	16.80	10.18	2.42	1.94	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	15.02	11.40	4.16	1.99	1.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	15.49	9.00	3.98	2.09	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	11.72	9.96	5.47	1.95	0.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	14.98	9.50	2.32	0.84	1.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	22.27	7.75	3.46	0.99	1.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	19.63	8.60	5.42	2.06	0.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	14.37	11.31	3.64	0.77	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	16.35	14.92	4.91	0.82	0.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	16.32	11.28	3.63	1.21	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	14.59	10.26	4.86	1.08	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	13.92	9.60	2.88	0.48	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	12.23	14.59	2.59	0.94	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	11.86	6.73	3.81	1.61	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	15.40	13.71	2.95	0.63	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	13.64	12.41	3.32	1.05	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	10.64	13.05	4.42	0.40	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	17.45	14.66	3.95	0.47	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	12.24	11.28	2.88	0.72	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	13.71	11.33	3.28	1.79	0.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	12.21	16.76	3.11	0.72	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	14.36	11.32	4.65	2.22	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	18.04	11.27	4.10	1.02	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	17.12	11.56	5.34	1.56	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	125.93	27.98	13.99	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	13.84	8.16	2.84	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	8.95	7.62	1.99	0.99	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	41.11	10.07	6.71	2.52	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	18.83	11.48	2.30	1.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	17.18	12.96	5.19	1.94	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	17.66	11.56	3.53	0.96	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	23.89	12.89	6.29	2.51	1.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	14.81	13.40	2.12	2.12	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	12.90	7.29	1.68	1.12	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	31.85	13.53	7.96	3.18	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	17.33	7.81	5.10	1.70	1.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	14.30	13.32	6.82	0.32	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	18.10	9.58	4.61	1.06	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	161.64	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	134.26	7.90	7.90	7.90	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	14.63	11.21	2.44	0.98	0.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	11.41	11.90	2.98	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	10.32	13.60	3.75	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	14.24	14.57	4.31	1.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	11.14	15.16	3.71	0.31	0.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	13.76	12.23	3.06	1.53	0.61
Adipocyte - breast, donor1	11376-118A8	14.73	26.93	6.18	1.58	0.00
Adipocyte - breast, donor2	11327-117E4	20.53	15.24	7.70	1.76	0.00
Adipocyte - omental, donor1	11473-119C6	16.92	9.54	11.32	0.76	0.76
Adipocyte - omental, donor2	11474-119C7	29.90	24.67	5.98	2.24	0.00
Adipocyte - omental, donor3	11475-119C8	32.15	15.74	3.35	2.34	0.33
Adipocyte - perirenal, donor1	11476-119C9	36.37	19.14	3.19	1.91	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	5.50	2.20	1.10	1.10	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	5.42	5.87	2.71	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	7.99	10.77	0.70	0.52	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	16.62	22.49	6.85	2.74	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	13.64	10.04	4.12	0.77	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	11.43	12.54	2.51	0.84	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	8.82	22.92	5.29	0.59	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	13.27	15.44	4.75	0.97	0.16
Adipocyte differentiation, day08, donor2	13023-139D8	16.14	13.88	3.87	1.61	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	10.66	8.53	2.13	1.07	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	9.46	11.13	2.78	2.23	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	17.05	14.97	7.90	0.83	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	13.06	11.55	4.27	0.75	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	11.13	13.09	3.27	0.98	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	7.00	16.14	2.13	0.61	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	12.15	9.72	5.08	1.77	0.44
Alveolar Epithelial Cells, donor2	11590-120G6	10.04	3.94	2.15	1.08	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	5.99	10.78	0.00	1.20	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	9.18	7.02	3.24	2.16	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	13.39	6.69	0.00	3.35	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	9.66	8.42	2.26	1.85	0.21
Anulus Pulposus Cell, donor1	11248-116E6	9.04	21.74	2.75	0.69	0.11
Anulus Pulposus Cell, donor2	11463-119B5	8.82	22.53	1.71	1.22	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	40.44	13.03	6.29	1.80	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	30.82	9.55	3.91	2.17	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	32.10	12.84	8.56	2.14	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	35.87	6.58	4.18	2.09	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	36.67	12.65	7.59	3.79	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	23.76	10.56	1.98	2.64	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	28.27	9.75	5.52	1.62	0.65
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	26.70	11.17	3.40	0.49	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	25.54	10.10	5.34	1.78	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	34.65	9.79	5.27	1.51	0.75
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	33.38	13.06	6.53	1.45	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	16.30	8.78	2.51	5.02	2.51
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	11.20	10.21	2.64	1.65	0.33
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	30.03	9.55	5.46	2.73	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	14.93	17.79	4.83	1.51	0.30
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	32.68	6.43	5.89	2.68	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	30.23	10.96	6.42	0.94	0.19
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	26.19	11.49	5.35	1.60	0.27
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	42.92	5.85	0.98	2.93	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	30.85	9.79	3.48	1.49	0.33
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	22.81	12.01	2.40	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	21.24	3.54	0.00	3.54	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	30.36	10.29	3.26	2.57	0.51
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	16.78	8.39	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	36.89	12.14	7.77	2.43	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	22.39	14.04	5.31	1.14	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	27.86	12.11	6.06	3.63	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	43.89	11.40	6.27	2.85	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	29.71	12.61	6.20	1.92	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	24.26	12.65	4.13	1.29	0.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	29.56	10.32	2.82	1.41	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	34.08	12.86	3.22	1.61	0.64
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	24.26	9.27	7.85	2.14	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	35.68	7.60	4.09	4.68	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	39.44	9.33	3.01	1.20	0.60
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	45.14	9.50	8.32	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	27.97	8.65	3.56	3.05	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	31.07	9.42	5.35	2.55	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	23.51	15.25	3.18	1.91	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	27.19	7.34	6.90	1.29	1.29
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	35.56	13.76	4.87	1.69	0.42
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	22.33	13.92	2.90	1.74	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	37.79	12.28	4.72	0.94	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	27.80	11.87	3.90	1.70	0.34
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	13.90	18.53	4.63	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	42.25	8.45	2.11	4.23	4.23
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	27.87	11.58	5.57	1.29	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	33.09	6.62	4.81	2.41	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	55.40	11.66	4.37	0.73	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	28.97	9.43	5.75	1.15	0.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	15.30	12.75	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	18.05	15.51	7.88	1.02	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	32.00	12.39	5.16	0.83	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	28.76	13.46	3.67	0.92	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	36.81	12.43	7.65	2.39	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	37.03	10.87	3.10	2.66	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	25.94	18.31	1.53	3.05	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	49.30	12.19	8.86	1.66	0.55
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	36.01	13.50	3.97	1.59	0.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	34.16	13.81	4.36	0.73	0.36
Astrocyte - cerebellum, donor1	11500-119F6	13.88	10.19	1.97	1.23	0.61
Astrocyte - cerebellum, donor2	11580-120F5	9.58	8.39	1.71	0.68	0.00
Astrocyte - cerebellum, donor3	11661-122F5	5.66	6.50	1.26	0.42	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	25.10	8.71	6.62	2.44	1.05
Astrocyte - cerebral cortex, donor2	11316-117D2	26.85	11.16	2.75	3.24	0.65
Astrocyte - cerebral cortex, donor3	11392-118C6	30.58	11.93	4.33	1.34	0.60
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	14.45	15.60	0.80	2.29	1.38
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	15.28	16.79	1.63	1.63	0.88
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	15.02	12.06	1.25	2.28	1.48
Basophils, donor1	12241-129G9	27.98	37.40	10.46	1.83	1.05
Basophils, donor2	12242-129H1	26.70	49.43	12.63	4.33	1.08
Basophils, donor3	12243-129H2	19.99	38.81	9.55	1.62	1.03
Bronchial Epithelial Cell, donor1	11511-119G8	5.39	6.90	1.29	0.65	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	5.94	4.11	0.91	0.46	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	7.17	14.35	7.17	7.17	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	1.88	7.53	2.51	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	4.37	7.49	0.42	0.62	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	3.22	10.59	3.22	0.46	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	16.91	9.72	1.44	0.54	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	23.81	11.23	3.61	2.16	0.31
Burkitt's lymphoma cell line:RAJI	10476-106I8	31.21	13.74	2.33	0.93	1.86
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	23.66	41.25	8.95	5.76	1.92
CD133+ stem cells - cord blood derived, pool1	12223-129E9	10.34	41.37	10.34	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	33.81	25.92	5.64	2.82	0.56
CD14+ Monocytes, donor2	11305-117B9	41.76	31.55	6.31	2.04	0.37
CD14+ Monocytes, donor3	11381-118B4	45.00	39.08	9.88	2.85	1.10
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	12.74	27.46	5.09	1.42	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	11.75	32.60	6.82	2.27	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	11.51	27.61	4.60	2.63	0.66
CD14+ monocytes - mock treated, donor1	11863-125A9	44.95	44.95	12.58	6.07	0.87
CD14+ monocytes - mock treated, donor2	11873-125C1	44.66	46.77	15.09	3.32	0.60
CD14+ monocytes - mock treated, donor3	11883-125D2	41.46	46.43	15.63	6.87	0.47
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	41.35	33.14	9.54	5.52	0.50
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	48.03	52.72	16.56	8.83	0.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	56.03	55.29	15.62	13.64	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	69.71	44.25	14.69	8.42	1.76
CD14+ monocytes - treated with BCG, donor2	11870-125B7	54.66	58.93	18.16	6.23	0.36
CD14+ monocytes - treated with BCG, donor3	11880-125C8	60.50	72.69	22.20	11.32	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	71.17	45.42	13.11	18.96	1.17
CD14+ monocytes - treated with Candida, donor2	11878-125C6	78.68	67.06	24.29	24.82	1.58
CD14+ monocytes - treated with Candida, donor3	11888-125D7	54.36	80.98	12.20	33.28	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	49.83	50.13	9.07	7.29	0.74
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	44.90	40.71	12.57	5.79	0.40
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	47.68	57.88	17.49	8.54	0.42
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	76.64	50.79	14.87	10.75	0.92
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	44.79	44.11	17.19	9.50	0.90
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	55.43	53.25	17.02	12.66	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	63.48	53.80	15.06	6.99	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	67.52	56.00	18.14	4.54	0.17
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	71.54	68.17	23.57	10.94	0.84
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	39.31	28.84	13.59	6.61	1.10
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	34.87	51.08	18.32	5.28	1.41
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	41.68	36.85	12.72	8.34	0.88
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	74.28	56.67	12.03	15.69	0.52
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	78.42	62.07	18.21	13.01	1.86
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	62.29	68.54	26.08	14.87	1.29
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	45.86	32.76	6.55	6.55	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	42.65	38.71	11.59	7.42	0.70
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	41.99	57.30	11.14	8.82	1.62
CD14+CD16+ Monocytes, donor1	11789-124B7	11.99	22.01	4.80	1.96	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	13.63	33.73	5.08	1.39	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	11.70	18.85	3.90	1.30	0.43
CD14+CD16- Monocytes, donor1	11788-124B6	12.77	32.39	6.38	2.49	0.47
CD14+CD16- Monocytes, donor2	11799-124C8	13.80	27.42	3.67	3.84	0.87
CD14+CD16- Monocytes, donor3	11910-125G2	16.95	25.42	5.35	1.34	0.22
CD14-CD16+ Monocytes, donor1	11790-124B8	12.50	47.46	7.14	1.02	0.26
CD14-CD16+ Monocytes, donor2	11800-124C9	14.93	36.89	7.03	2.20	0.22
CD14-CD16+ Monocytes, donor3	11911-125G3	12.42	26.32	5.68	2.11	0.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	12.19	54.87	8.13	6.10	2.03
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	14.24	50.85	4.07	4.07	2.71
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	11.39	53.85	8.28	6.21	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	26.12	38.38	6.40	4.26	5.33
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	17.69	46.64	7.50	3.75	2.14
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	13.34	46.33	5.62	2.81	2.11
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	17.26	50.20	7.06	1.57	2.35
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	11.86	67.23	13.18	1.32	1.32
CD19+ B Cells, donor1	11544-120B5	45.20	22.19	3.29	2.47	5.75
CD19+ B Cells, donor2	11624-122B4	34.82	21.04	11.61	4.35	1.45
CD19+ B Cells, donor3	11705-123B4	42.41	24.74	11.11	2.02	2.02
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	51.32	101.42	20.61	2.02	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	54.33	91.88	25.57	1.60	0.00
CD34+ Progenitors, donor1	11545-120B6	25.10	24.10	6.02	1.00	0.00
CD34+ Progenitors, donor2	11625-122B5	62.92	82.59	23.60	1.69	1.69
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	15.41	19.92	4.13	3.76	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	15.56	21.42	3.83	1.58	0.90
CD4+ T Cells, donor1	11225-116C1	43.92	59.99	28.92	3.57	1.43
CD4+ T Cells, donor2	11306-117C1	92.47	64.30	14.70	4.90	2.45
CD4+ T Cells, donor3	11382-118B5	40.56	46.66	12.20	3.35	1.83
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	10.98	31.39	8.42	4.08	0.77
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	22.91	41.78	7.41	2.70	0.90
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	19.55	35.65	8.34	2.01	1.15
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	36.03	65.90	27.02	5.22	2.84
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	33.01	76.55	24.58	7.02	5.62
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	29.67	56.04	3.30	3.30	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	12.57	27.02	6.65	2.02	0.87
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	19.49	35.42	6.27	2.20	0.68
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	19.67	24.02	4.51	2.42	0.48
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	38.11	53.80	21.07	3.14	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	30.05	43.67	17.47	3.84	0.70
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	20.24	40.04	11.88	2.64	0.88
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	16.44	25.30	7.17	3.37	1.26
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	24.10	34.91	4.78	2.91	0.62
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	20.05	23.72	4.68	2.00	0.33
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	19.31	63.90	16.32	5.44	1.63
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	20.90	50.38	20.37	4.29	1.61
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	39.45	44.83	16.14	7.17	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	9.46	28.56	7.23	4.26	1.30
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	8.01	33.79	5.85	1.95	0.65
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	12.40	27.74	6.72	1.26	1.05
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	20.73	43.48	19.72	5.56	2.02
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	14.73	52.86	14.73	4.33	3.03
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	17.00	41.84	14.38	4.36	2.18
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	13.36	67.30	12.37	9.40	2.47
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	13.85	65.55	12.92	7.39	3.69
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	18.15	75.37	11.17	5.58	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	24.65	64.25	8.03	6.37	2.49
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	19.88	58.65	12.02	4.91	1.72
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	10.78	52.36	12.32	3.08	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	13.61	58.37	6.80	6.09	2.15
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	22.16	74.79	8.31	5.54	1.38
CD8+ T Cells, donor1	11226-116C2	34.05	34.05	19.64	3.93	1.64
CD8+ T Cells, donor2	11307-117C2	66.83	42.05	16.89	6.01	1.50
CD8+ T Cells, donor3	11383-118B6	68.42	52.52	19.95	5.30	3.53
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	32.34	7.57	37.39	1.15	0.46
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	20.61	6.71	26.60	1.68	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	21.89	6.84	23.53	1.09	1.09
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	38.43	7.21	45.03	0.90	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	24.48	8.64	30.00	1.44	0.24
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	29.79	9.10	36.84	1.82	0.68
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	37.37	8.91	49.32	1.96	0.43
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	35.53	8.42	39.48	2.90	0.53
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	33.77	8.21	44.32	1.88	0.23
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	38.04	9.66	48.60	2.72	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	39.22	9.01	39.51	1.74	0.29
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	33.30	13.32	49.29	2.13	0.27
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	73.10	14.01	67.85	3.94	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	76.97	22.77	70.14	3.19	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	69.37	11.93	79.06	2.24	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	33.13	10.08	43.22	1.44	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	34.53	7.19	41.14	1.73	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	32.53	9.43	32.76	0.71	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	43.42	11.41	57.36	1.90	0.95
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	51.98	10.46	56.59	4.00	0.62
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	39.75	9.30	55.14	1.28	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	39.78	16.06	54.69	3.06	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	48.08	14.58	50.05	3.15	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	45.38	12.86	47.65	0.76	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	144.53	36.13	82.70	4.82	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	141.28	41.27	100.72	9.79	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	148.26	47.08	136.24	12.02	1.00
Cardiac Myocyte, donor1	11525-119I4	23.76	25.59	5.48	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	13.83	3.46	3.46	0.49	0.00
Cardiac Myocyte, donor3	11686-122I3	11.26	10.21	2.84	0.84	0.32
Chondrocyte - de diff, donor1	11261-116G1	23.57	33.63	2.77	1.39	0.69
Chondrocyte - de diff, donor2	11338-117F6	6.40	13.15	1.07	1.42	0.00
Chondrocyte - de diff, donor3	11410-118E6	25.71	14.91	4.10	2.73	0.34
Chondrocyte - re diff, donor2	11339-117F7	7.16	18.80	1.79	2.69	0.00
Chondrocyte - re diff, donor3	11411-118E7	14.56	21.43	4.45	2.83	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	18.36	11.13	3.21	1.49	0.46
Ciliary Epithelial Cells, donor2	11323-117D9	23.73	11.97	3.85	1.50	0.43
Ciliary Epithelial Cells, donor3	11399-118D4	18.76	9.73	2.65	1.15	0.62
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	24.30	14.67	6.79	1.19	0.83
Corneal Epithelial Cells, donor1	11526-119I5	3.95	4.17	1.10	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	7.96	4.55	0.00	0.00	1.14
Corneal Epithelial Cells, donor3	11687-122I4	9.46	5.62	1.79	0.26	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	7.76	22.29	2.15	0.83	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	10.41	22.71	2.84	2.52	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	6.90	41.41	0.00	6.90	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	8.96	20.09	1.94	0.97	0.43
Dendritic Cells - plasmacytoid, donor1	11228-116C4	19.47	14.01	5.12	2.05	2.05
Dendritic Cells - plasmacytoid, donor2	11309-117C4	15.02	37.87	3.26	1.31	1.31
Dendritic Cells - plasmacytoid, donor3	11385-118B8	14.03	48.39	9.19	2.90	2.42
Endothelial Cells - Aortic, donor0	11207-116A1	8.00	11.67	4.50	2.17	0.67
Endothelial Cells - Aortic, donor1	11263-116G3	5.87	16.43	1.76	0.59	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	8.48	9.33	4.52	0.85	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	8.26	11.40	3.15	1.18	0.00
Endothelial Cells - Artery, donor1	11264-116G4	8.14	11.34	2.33	2.04	0.58
Endothelial Cells - Artery, donor2	11341-117F9	13.88	8.23	6.12	1.65	0.00
Endothelial Cells - Artery, donor3	11413-118E9	6.84	10.52	1.93	1.58	0.18
Endothelial Cells - Lymphatic, donor1	11236-116D3	12.63	13.96	6.21	2.44	0.44
Endothelial Cells - Lymphatic, donor2	11317-117D3	10.04	16.73	9.13	1.52	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	10.43	7.89	7.89	3.66	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	21.39	7.13	2.97	0.30	0.59
Endothelial Cells - Microvascular, donor2	11342-117G1	4.17	10.41	6.25	2.08	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	11.48	6.66	1.99	1.28	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	38.01	14.80	10.80	1.60	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	17.30	7.86	3.67	1.05	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	16.77	8.57	4.22	2.86	0.12
Endothelial Cells - Umbilical vein, donor2	11324-117E1	15.86	9.34	2.82	0.43	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	11.24	13.19	4.40	1.10	0.12
Endothelial Cells - Vein, donor1	11267-116G7	6.83	6.83	0.00	2.28	0.00
Endothelial Cells - Vein, donor2	11344-117G3	1.40	7.68	2.79	2.79	0.00
Endothelial Cells - Vein, donor3	11416-118F3	14.13	10.21	3.93	1.57	0.16
Eosinophils, donor1	12244-129H3	0.00	45.74	15.25	0.00	15.25
Eosinophils, donor2	12245-129H4	148.52	473.63	56.11	6.60	3.30
Eosinophils, donor3	12246-129H5	121.27	385.22	21.40	3.57	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	3.66	6.60	1.71	0.49	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	14.56	8.32	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	32.54	48.81	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	24.63	33.66	8.62	1.23	0.82
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	6.57	16.31	4.16	0.44	0.33
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	10.94	11.59	2.82	0.43	0.00
Fibroblast - Aortic Adventitial, donor1	11245-116E3	20.62	11.40	3.52	2.06	0.49
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	8.60	18.56	3.96	2.87	0.96
Fibroblast - Aortic Adventitial, donor2	11326-117E3	19.41	13.92	3.06	1.27	0.00
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	8.70	5.27	1.05	2.90	0.26
Fibroblast - Aortic Adventitial, donor3	11401-118D6	25.58	12.29	4.98	1.99	0.33
Fibroblast - Cardiac, donor1	11268-116G8	10.89	9.07	2.72	4.08	0.45
Fibroblast - Cardiac, donor2	11345-117G4	10.61	8.34	3.03	0.76	0.00
Fibroblast - Cardiac, donor3	11417-118F4	11.83	10.72	3.00	1.26	0.32
Fibroblast - Cardiac, donor4	11452-119A3	8.49	17.58	1.82	1.21	0.00
Fibroblast - Cardiac, donor5	11456-119A7	19.29	18.78	5.84	2.16	0.00
Fibroblast - Cardiac, donor6	11460-119B2	25.01	12.58	3.79	1.36	0.00
Fibroblast - Choroid Plexus, donor1	11492-119E7	13.94	10.05	2.95	2.01	0.67
Fibroblast - Choroid Plexus, donor2	11572-120E6	20.71	15.10	3.45	0.86	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	26.37	10.25	2.93	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	5.07	7.15	2.08	0.69	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	6.11	16.96	2.71	1.19	0.34
Fibroblast - Dermal, donor1	11269-116G9	9.86	10.57	2.35	0.70	0.47
Fibroblast - Dermal, donor2	11346-117G5	4.25	10.38	3.77	0.47	0.00
Fibroblast - Dermal, donor3	11418-118F5	22.12	16.08	2.30	1.09	0.12
Fibroblast - Dermal, donor4	11450-119A1	19.33	7.91	3.73	1.13	0.23
Fibroblast - Dermal, donor5	11454-119A5	22.68	12.04	3.66	1.57	0.35
Fibroblast - Dermal, donor6	11458-119A9	24.20	12.51	3.57	2.27	0.32
Fibroblast - Gingival, donor1	11237-116D4	11.04	13.33	2.92	0.83	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	15.20	21.75	2.62	2.36	0.52
Fibroblast - Gingival, donor2	11318-117D4	17.40	13.71	3.82	1.05	0.40
Fibroblast - Gingival, donor3	11394-118C8	9.77	11.70	3.38	2.03	0.10
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	29.09	27.01	2.08	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	23.61	17.09	3.88	1.23	0.35
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	15.28	12.94	2.65	0.94	0.31
Fibroblast - Gingival, donor6 (control)	11922-125H5	13.39	10.01	1.35	1.49	0.41
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	0.71	4.59	0.71	1.06	0.71
Fibroblast - Gingival, donor7 (control)	11924-125H7	14.48	18.72	3.66	1.02	0.15
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	12.54	13.36	2.45	1.23	0.14
Fibroblast - Gingival, donor8 (control)	11926-125H9	14.70	16.56	3.40	2.30	0.33
Fibroblast - Gingival, donor9 (control)	11927-125I1	12.03	26.27	3.67	1.32	0.29
Fibroblast - Lung, donor1	11270-116H1	9.52	10.87	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	14.92	19.40	4.48	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	13.08	12.24	1.90	1.69	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	6.66	5.00	6.66	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	9.79	4.20	1.40	4.20	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	4.20	3.08	1.68	0.56	0.00
Fibroblast - Mammary, donor1	11540-120B1	2.84	8.93	3.25	3.25	0.00
Fibroblast - Mammary, donor2	11620-122A9	7.99	11.98	3.99	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	5.96	5.96	17.87	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	21.14	9.12	2.33	1.16	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	20.48	12.13	3.49	2.28	0.61
Fibroblast - Periodontal Ligament, donor3	11395-118C9	5.20	10.10	4.59	0.92	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	13.36	8.40	2.67	1.14	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	27.00	14.85	3.51	0.54	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	18.67	23.89	3.83	1.62	0.23
Fibroblast - Pulmonary Artery, donor1	11250-116E8	17.69	21.77	3.98	2.21	0.44
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	4.47	8.53	1.83	1.22	0.61
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	10.69	11.36	2.67	0.67	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	12.65	8.30	2.77	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	9.33	3.18	1.79	3.57	0.79
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	14.03	17.23	4.09	2.66	0.36
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	14.98	10.05	4.93	2.17	0.39
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	5.42	4.51	1.81	3.91	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	13.49	13.17	4.75	1.51	0.22
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	8.86	6.33	1.52	4.81	1.01
Fibroblast - skin normal, donor1	11553-120C5	11.16	9.84	4.27	1.97	0.33
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	10.83	8.82	1.60	2.41	0.60
Fibroblast - skin normal, donor2	11561-120D4	17.68	23.91	4.22	2.71	0.30
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	6.95	5.74	1.21	4.84	1.21
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	17.07	15.00	4.72	4.47	0.33
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	17.78	12.99	4.27	3.76	0.68
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	8.54	7.23	0.33	1.64	0.66
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	19.28	14.59	5.22	1.49	0.21
Fibroblast - skin walker warburg, donor1	11554-120C6	11.64	14.34	3.71	2.70	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	15.37	14.27	2.98	1.41	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	177.28	22.16	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	13.94	49.68	3.49	0.87	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	9.36	21.67	6.59	1.91	0.52
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	11.97	15.87	6.25	1.04	0.26
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	8.18	16.35	5.88	1.02	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	22.97	6.12	1.53	0.77	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	36.37	10.21	2.55	3.83	1.91
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	58.19	14.55	5.71	5.71	1.71
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	46.33	14.89	2.21	2.48	0.55
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	42.01	15.98	2.51	2.05	1.14
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	40.02	14.86	3.57	4.36	1.98
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	49.43	13.48	2.91	1.59	1.85
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	46.64	15.00	2.61	1.96	1.30
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	38.03	15.92	3.10	6.19	1.77
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	20.63	9.61	2.69	4.52	0.71
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	18.96	12.19	3.82	2.46	1.60
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	17.46	8.06	0.81	2.42	0.81
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	24.28	11.27	4.46	2.48	0.50
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	21.59	11.77	3.05	3.05	0.69
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	19.31	6.71	1.42	2.64	1.02
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	21.45	7.99	3.19	2.74	1.14
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	19.56	11.71	3.61	3.61	0.87
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	16.39	13.11	3.06	2.62	0.66
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	27.18	6.80	3.55	2.36	0.59
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	26.39	9.54	5.40	3.50	0.48
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	14.08	9.38	2.01	2.90	0.67
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	21.98	4.84	2.62	3.43	0.60
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	31.89	9.33	2.88	2.88	1.02
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	21.55	8.34	2.84	2.39	0.98
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	17.17	4.16	3.12	2.91	1.04
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	15.71	3.93	2.39	2.73	0.51
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	20.91	11.62	4.32	3.54	1.22
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	20.47	8.40	3.16	3.91	0.75
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	21.64	6.33	5.51	2.04	0.82
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	28.26	8.66	1.86	2.68	1.44
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	23.87	12.22	3.57	3.69	0.58
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	25.52	9.51	5.17	3.17	1.67
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	26.45	5.95	1.98	4.19	0.44
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	21.28	12.30	5.04	3.07	0.74
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	23.99	9.08	1.46	3.24	0.81
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	29.19	12.51	3.53	5.77	1.28
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	15.63	9.76	4.36	2.27	0.66
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	20.56	4.75	3.64	2.53	0.95
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	27.98	8.82	5.17	4.56	1.82
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	29.27	11.60	4.08	3.45	0.73
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	19.54	8.78	3.29	3.51	0.88
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	24.69	8.42	3.09	2.52	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	14.26	7.31	6.94	2.41	0.46
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	24.60	7.49	4.28	0.53	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	23.10	5.97	5.05	2.30	0.31
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	19.56	10.36	5.44	2.98	0.26
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	20.33	8.95	5.69	1.63	0.54
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	21.94	8.48	4.79	2.77	0.74
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	16.45	9.65	3.51	2.41	0.88
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	8.93	6.94	1.98	5.95	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	20.18	8.57	2.77	2.77	0.13
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	15.74	8.07	3.23	2.22	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	6.61	5.08	2.80	2.54	0.51
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	18.91	5.97	3.18	4.78	1.19
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	15.87	11.56	2.77	3.39	1.85
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	25.37	8.39	3.07	5.93	3.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	34.11	8.45	3.13	1.25	0.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	31.65	8.76	2.54	1.41	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	38.74	8.30	1.84	3.69	0.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	29.70	17.32	2.47	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	49.12	9.67	5.80	5.03	1.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	60.97	12.84	4.81	3.21	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	36.52	10.43	1.74	1.74	3.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	48.17	10.09	2.28	1.30	1.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	50.24	11.53	3.71	2.47	2.06
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	69.98	6.66	3.33	3.33	6.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	34.68	8.11	1.68	2.52	2.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	40.53	6.54	4.90	1.96	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	42.78	11.74	0.84	2.52	1.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	30.22	8.91	2.23	3.18	1.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	30.23	5.77	2.72	4.42	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	54.29	8.35	4.18	0.00	4.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	46.96	8.59	1.72	1.72	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	23.38	3.26	1.18	2.66	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	44.05	10.16	0.00	3.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	43.08	5.80	1.66	4.97	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	30.61	6.90	2.76	2.07	0.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	42.15	21.07	5.27	5.27	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	38.83	6.92	2.31	3.08	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	37.81	7.50	3.26	1.63	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	38.79	19.40	3.34	5.35	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	43.92	10.40	3.08	5.01	2.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	46.90	3.42	3.08	3.42	2.05
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	32.30	12.42	9.94	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	41.99	8.97	4.25	1.89	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	42.85	6.64	3.02	3.02	1.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	36.62	11.19	4.07	7.12	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	45.87	14.36	5.18	3.59	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	58.22	9.87	2.96	4.93	0.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	57.84	14.17	7.08	1.18	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	54.84	8.75	6.42	3.50	1.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	43.01	10.09	4.39	3.07	0.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	47.47	16.11	5.93	3.39	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	53.13	10.15	4.18	2.39	1.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	40.28	14.56	1.46	4.85	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	6.85	9.13	1.14	1.14	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	8.73	7.07	0.00	0.83	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	0.00	9.00	2.25	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	25.37	12.69	2.22	0.63	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	11.70	6.27	0.84	0.42	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	17.99	8.01	1.62	1.51	0.35
Hep-2 cells mock treated, biol_rep2	11899-125E9	16.71	9.45	5.06	0.84	0.17
Hep-2 cells mock treated, biol_rep3	11900-125F1	18.66	7.96	2.50	0.68	0.46
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	18.36	8.74	3.72	0.55	0.44
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	15.69	7.95	4.30	0.86	0.21
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	15.72	9.04	3.44	0.00	0.43
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	18.56	8.34	3.74	0.87	0.25
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	21.44	6.69	2.57	0.86	0.34
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	13.46	9.61	3.52	0.32	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	12.87	6.72	2.80	3.36	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	9.09	5.63	3.90	1.73	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	23.79	10.58	0.00	7.93	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	6.70	8.82	3.17	1.41	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	10.17	4.36	3.63	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	26.23	6.82	1.92	0.17	0.00
Hepatocyte, donor1	11523-119I2	32.69	13.32	3.63	2.42	0.00
Hepatocyte, donor2	11603-120I1	35.55	7.54	9.70	5.39	1.08
Hepatocyte, donor3	11684-122I1	29.45	22.70	4.29	1.84	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	31.98	20.23	7.18	2.61	5.22
Intestinal epithelial cells (polarized), donor1	11246-116E4	24.82	16.25	4.54	3.50	0.70
Iris Pigment Epithelial Cells, donor1	11530-119I9	11.39	8.10	2.20	1.37	0.14
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	3.18	3.18	3.18	3.18	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	6.68	0.00	6.68	6.68	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	5.54	0.00	0.00	6.92	1.38
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	2.50	7.51	2.50	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	11.87	23.74	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	5.13	12.81	5.13	2.56	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	4.57	13.71	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	6.50	8.12	1.62	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	5.00	6.67	1.67	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	3.63	3.63	0.00	0.00	3.63
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	2.65	5.29	1.32	3.97	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	2.22	2.22	1.11	0.00	1.11
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	0.00	10.48	5.24	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	8.19	3.78	1.89	1.89	0.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	0.00	3.09	0.00	1.55	1.55
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	14.63	0.00	14.63	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	1.29	3.88	1.94	2.58	0.65
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	8.05	4.83	3.22	1.61	3.22
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	0.00	11.95	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	6.52	3.26	0.81	2.44	2.44
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	0.84	2.10	1.68	0.42	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	0.00	0.00	14.37	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	4.82	3.21	4.02	2.41	2.41
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	3.69	0.00	0.00	0.92	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	4.25	6.61	2.36	0.47	0.94
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	5.44	2.72	1.81	0.91	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	0.00	14.74	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	5.38	8.61	1.08	2.15	3.23
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	3.81	1.27	3.81	0.00	1.27
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	16.43	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	4.46	6.38	3.19	1.91	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	3.65	3.65	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	15.80	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	2.86	1.43	0.71	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	3.32	6.64	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	20.85	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	3.40	6.17	3.09	1.85	0.93
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	0.00	3.51	1.76	3.51	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	3.14	3.14	0.00	9.43	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	1.39	2.09	1.39	4.87	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	0.00	0.00	2.21	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	3.24	3.24	0.00	3.24	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	3.49	6.10	0.87	1.74	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	0.00	4.50	0.00	2.25	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	6.97	10.45	3.48	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	6.40	4.27	2.13	1.07	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	2.77	0.00	2.77	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	2.85	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	0.92	4.60	3.68	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	2.11	7.40	2.11	1.06	0.00
Keratinocyte - epidermal, donor1	11272-116H3	7.51	4.81	1.22	0.33	0.00
Keratinocyte - epidermal, donor2	11349-117G8	1.17	7.61	1.76	0.59	0.00
Keratinocyte - epidermal, donor3	11421-118F8	15.33	7.19	2.75	1.04	0.09
Keratinocyte - oral, donor1	11251-116E9	23.16	13.40	2.95	1.48	0.34
Keratocytes, donor1	11527-119I6	15.47	12.72	3.09	1.03	0.00
Keratocytes, donor2	11607-120I5	14.06	9.37	3.52	0.00	0.00
Keratocytes, donor3	11688-122I5	13.44	7.71	3.75	0.59	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	26.37	17.58	15.39	0.00	2.20
Lens Epithelial Cells, donor1	11529-119I8	30.20	5.39	4.31	1.08	0.00
Lens Epithelial Cells, donor2	11609-120I7	12.92	10.15	3.11	1.96	0.58
Lens Epithelial Cells, donor3	11690-122I7	6.96	10.90	2.72	1.72	0.10
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	16.48	12.92	4.86	2.96	0.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	29.30	6.42	1.67	2.51	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	42.66	10.23	5.35	2.83	0.63
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	34.95	11.83	5.38	2.69	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	16.70	4.73	0.95	0.95	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	23.50	6.79	3.67	1.94	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	31.19	14.36	4.10	3.69	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	15.67	4.80	3.79	1.77	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	20.83	7.18	3.38	2.25	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	35.60	13.05	5.14	1.98	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	29.28	7.56	2.91	3.30	0.97
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	10.37	3.89	1.85	1.48	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	27.18	15.68	4.18	2.44	0.70
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	23.38	7.16	3.10	1.67	0.48
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	20.19	6.04	3.43	1.79	0.14
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	32.95	13.55	3.08	2.16	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	10.91	6.55	2.49	0.62	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	17.02	7.14	1.83	1.65	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	26.33	10.86	4.28	2.96	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	16.11	6.15	2.93	1.46	0.29
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	17.43	4.73	1.99	1.24	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	30.07	9.21	6.30	1.94	1.45
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	25.58	7.00	5.12	2.42	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	28.46	6.81	3.33	2.27	0.61
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	21.77	12.44	3.63	3.63	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	27.01	9.00	4.40	2.93	0.84
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	24.66	5.26	4.06	2.11	0.30
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	28.89	11.69	2.06	4.13	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	22.01	5.08	3.20	3.01	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	18.77	5.83	2.12	2.12	0.32
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	29.07	12.60	5.33	3.39	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	23.16	6.62	1.65	1.32	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	23.79	5.33	2.97	1.36	0.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	32.95	12.22	5.18	4.44	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	24.96	8.15	3.21	1.48	0.49
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	20.35	5.64	2.89	2.61	0.27
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	28.63	11.58	3.86	2.57	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	33.48	8.22	4.87	3.96	0.91
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	36.95	8.12	4.48	2.52	0.28
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	33.42	16.71	4.62	3.20	1.42
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	13.57	4.36	2.42	1.94	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	14.32	4.98	2.18	1.56	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	26.86	10.74	4.30	2.51	0.72
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	24.50	7.19	2.61	2.29	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	18.13	3.77	2.59	1.65	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	17.08	15.84	5.57	1.86	0.12
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	15.11	4.10	2.31	2.05	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	25.96	6.56	6.56	2.09	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	9.06	15.86	0.00	6.80	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	12.27	13.04	3.07	3.84	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	10.39	17.07	1.48	2.97	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	18.19	13.54	1.27	2.96	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	19.69	5.63	2.11	3.52	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	14.01	10.27	0.93	4.67	0.93
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	16.49	9.27	1.55	3.61	1.03
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	16.65	8.33	1.19	5.95	2.38
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	6.56	9.27	1.58	2.04	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	32.57	7.85	2.33	2.91	1.16
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	23.41	8.10	1.80	2.25	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	7.59	9.08	1.22	3.25	0.54
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	27.22	10.78	4.11	4.11	1.03
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	24.70	7.06	3.18	1.06	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	11.33	8.66	0.67	5.33	1.33
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	23.43	10.70	2.04	4.58	1.02
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	19.48	9.61	1.33	2.40	0.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	24.37	7.37	2.65	2.08	0.94
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	12.27	7.98	3.07	4.29	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	13.86	9.79	0.82	4.08	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	28.32	10.00	2.92	2.71	0.83
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	32.23	12.33	3.64	2.52	1.40
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	16.49	9.27	2.06	7.21	2.06
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	25.26	11.61	2.61	3.19	0.29
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	24.51	9.57	3.59	1.79	0.60
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	19.92	7.19	2.21	0.55	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	22.62	6.36	1.77	2.12	0.71
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	22.13	6.64	2.95	6.27	2.21
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	10.36	3.45	4.61	1.15	2.30
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	21.49	9.21	1.92	3.07	1.54
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	18.12	7.36	1.13	1.70	1.13
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	7.38	9.03	1.64	4.92	1.64
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	15.36	9.04	0.45	4.52	0.90
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	17.24	8.62	0.72	2.15	0.72
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	17.93	8.22	2.24	5.98	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	18.58	6.69	1.49	3.34	1.11
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	19.38	10.34	1.29	3.45	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	11.99	14.56	1.71	5.14	1.71
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	18.32	5.33	2.00	6.00	0.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	16.89	10.86	6.03	4.22	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	12.09	4.98	0.00	4.27	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	20.62	10.66	0.69	3.78	1.72
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	14.49	7.51	0.54	4.29	1.07
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	8.75	11.45	1.35	5.39	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	18.52	9.63	1.85	4.82	1.48
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	3.49	15.12	0.00	4.65	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	10.58	8.46	0.00	1.06	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	22.01	6.80	2.40	5.60	1.20
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	10.90	13.81	0.73	4.36	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	17.63	9.96	2.30	3.83	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	19.73	8.88	4.44	3.95	1.97
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	23.52	7.53	2.82	4.70	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	13.58	14.08	0.50	3.52	1.01
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	17.57	11.72	2.70	5.41	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	24.10	8.61	0.00	5.16	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	18.26	9.80	2.67	3.12	2.23
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	20.72	10.95	2.35	4.69	1.96
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	18.47	9.24	1.98	0.66	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	18.68	16.09	2.08	3.11	1.04
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	19.25	7.44	1.31	4.81	1.75
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	22.92	8.95	1.68	2.80	1.12
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	16.34	11.92	2.21	3.53	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	23.53	13.11	3.09	1.93	0.77
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	20.25	6.58	1.52	2.53	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	30.28	11.05	4.81	1.92	0.96
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	22.26	8.75	3.98	2.78	0.80
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	24.91	11.54	3.04	4.25	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	16.60	6.92	4.15	2.77	0.69
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	22.04	7.60	1.90	2.28	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	29.95	12.91	3.61	0.52	2.07
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	14.51	10.28	0.60	3.63	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	24.08	7.61	4.44	3.17	0.95
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	18.13	10.13	3.73	2.67	1.07
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	16.67	11.49	2.87	1.72	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	21.60	10.80	2.06	4.11	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	18.39	10.61	2.12	4.24	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	14.75	11.92	2.27	3.97	1.13
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	19.97	9.98	4.99	2.50	0.83
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	21.93	9.40	0.78	2.35	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	17.95	6.68	2.51	3.34	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	21.84	9.76	2.32	2.32	1.39
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	14.05	7.36	2.68	3.35	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	16.57	5.88	3.21	3.21	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	14.14	6.06	3.64	3.23	0.81
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	15.60	3.67	2.75	2.75	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	16.00	5.33	5.33	4.45	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	16.53	11.97	1.71	2.28	1.14
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	17.64	8.44	1.53	2.30	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	8.75	4.92	0.55	3.28	1.64
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	12.47	8.02	2.23	2.23	0.89
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	8.58	10.14	1.30	2.34	0.52
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	11.94	2.65	1.33	2.65	1.33
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	22.86	18.71	0.00	4.16	0.00
Macrophage - monocyte derived, donor1	11232-116C8	11.40	20.74	2.05	0.23	0.46
Macrophage - monocyte derived, donor2	11313-117C8	7.16	17.62	1.84	0.92	0.55
Macrophage - monocyte derived, donor3	11389-118C3	10.49	15.21	2.36	1.44	0.52
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	16.99	12.21	2.12	2.12	0.00
Mallassez-derived cells, donor2	11929-125I3	13.94	13.63	5.07	1.27	0.16
Mallassez-derived cells, donor3	11930-125I4	12.79	14.32	8.48	1.53	0.00
Mammary Epithelial Cell, donor1	11273-116H4	24.21	20.63	7.17	1.00	0.20
Mammary Epithelial Cell, donor2	11350-117G9	22.01	14.19	11.58	2.03	0.58
Mammary Epithelial Cell, donor3	11422-118F9	2.99	8.73	0.50	0.75	0.00
Mast cell - stimulated, donor1	11487-119E2	18.30	8.81	4.07	0.68	0.00
Mast cell, donor1	11563-120D6	10.71	17.52	4.97	1.51	0.32
Mast cell, donor2	11565-120D8	28.53	79.35	10.40	3.86	0.30
Mast cell, donor3	11566-120D9	43.45	89.82	8.10	2.93	0.68
Mast cell, donor4	11567-120E1	27.13	106.73	9.22	5.50	0.35
Mast cell, expanded and stimulated, donor5	11940-126A5	7.43	25.84	3.33	2.00	0.22
Mast cell, expanded and stimulated, donor8	11942-126A7	12.84	20.43	2.33	1.75	0.00
Mast cell, expanded, donor5	11939-126A4	8.95	23.75	1.61	1.38	0.23
Mast cell, expanded, donor8	11941-126A6	17.07	42.85	6.86	6.86	0.50
Melanocyte - dark, donor1	11502-119F8	16.52	11.64	4.08	2.59	0.10
Melanocyte - dark, donor2	11582-120F7	17.65	4.85	1.73	1.73	0.35
Melanocyte - dark, donor3	11663-122F7	24.63	8.84	6.37	0.58	0.22
Melanocyte - light, donor1	11274-116H5	4.47	5.88	3.06	0.94	0.47
Melanocyte - light, donor2	11351-117H1	2.05	4.78	1.36	2.05	0.00
Melanocyte - light, donor3	11423-118G1	10.41	6.94	0.00	2.60	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	18.95	13.33	5.00	1.67	0.10
Melanocyte, donor2 (MC+2)	12739-135I3	27.16	8.34	5.11	1.61	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	20.62	9.64	5.89	1.87	0.27
Meningeal Cells, donor1	11493-119E8	11.66	7.82	4.09	1.74	0.25
Meningeal Cells, donor2	11573-120E7	18.05	9.24	1.32	1.76	0.44
Meningeal Cells, donor3	11654-122E7	16.14	5.54	2.93	2.04	0.24
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	19.39	7.98	2.28	1.43	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	10.06	14.69	3.62	1.61	0.81
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	0.00	9.20	0.00	1.31	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	9.16	5.23	2.62	1.31	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	12.20	9.33	2.87	1.44	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	16.73	10.80	9.32	2.54	0.64
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	35.19	14.58	8.54	1.51	1.01
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	8.79	5.49	1.76	0.44	0.22
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	11.69	4.38	2.19	0.73	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	10.84	6.34	2.86	1.23	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	11.77	7.89	1.66	1.25	0.14
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	3.35	2.97	1.12	0.37	0.37
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	14.21	10.53	3.16	0.26	0.13
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	4.75	4.15	1.78	0.59	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	4.67	4.67	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	6.40	4.48	3.20	1.92	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	16.30	9.22	3.54	1.42	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	14.39	11.57	5.00	1.25	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	18.87	13.06	0.73	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	13.26	15.65	4.77	1.59	0.00
Mesothelial Cells, donor2	12156-128G5	5.00	12.01	5.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	10.41	14.60	2.38	1.37	0.14
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	6.75	14.85	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	18.47	16.99	3.20	0.99	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	9.13	17.08	3.24	0.88	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	0.00	3.46	3.46	3.46	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	12.71	13.95	3.72	1.55	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	16.18	9.54	2.28	0.62	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	2.32	0.00	2.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	19.02	14.26	3.50	1.00	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	8.84	15.36	2.79	0.93	0.93
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	38.93	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	15.44	14.83	2.64	1.02	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	8.32	13.46	1.58	0.79	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	8.55	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	13.27	7.08	0.88	0.88	0.88
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	15.96	12.16	1.90	2.28	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	0.00	17.11	1.32	0.00	1.32
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	16.34	14.43	1.91	1.70	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	1.84	11.05	2.76	0.92	0.92
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	13.11	11.62	2.98	1.79	0.60
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	1.68	3.35	0.00	1.68	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	33.95	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	24.34	12.29	3.01	1.51	0.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	7.84	13.07	1.43	0.48	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	4.98	17.14	3.87	0.55	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	22.10	8.29	2.76	0.92	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	8.20	12.83	1.68	0.63	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	8.36	9.17	1.83	0.82	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	23.17	12.01	3.65	1.07	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	8.45	10.89	1.56	1.56	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	9.64	14.24	3.94	0.88	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	6.08	8.62	2.03	0.51	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	3.31	14.91	1.66	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	14.13	14.40	5.44	0.27	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	7.06	15.88	2.65	1.47	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	3.27	10.90	5.45	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	18.74	14.90	2.88	0.48	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	12.41	14.41	3.20	0.00	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	16.45	4.11	5.48	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	25.03	12.51	3.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	26.95	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	6.12	8.15	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	27.59	20.58	6.57	0.88	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	8.83	11.04	7.73	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	7.68	8.97	3.84	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	30.99	14.38	5.21	0.50	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	8.35	17.40	2.78	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	8.84	17.68	0.00	2.21	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	23.93	15.38	2.74	0.34	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	8.31	21.01	1.75	0.44	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	13.49	10.65	4.26	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	23.85	15.43	4.49	1.40	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	6.23	16.21	4.16	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	6.41	12.24	1.75	0.00	0.58
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	18.70	18.70	4.83	1.51	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	12.10	21.70	4.17	0.42	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	0.00	7.22	7.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	17.55	14.78	3.69	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	14.80	16.50	2.28	1.14	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	7.88	16.31	4.97	0.55	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	22.03	16.84	2.33	1.04	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	11.58	17.59	5.15	0.86	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	5.08	8.26	1.91	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	11.48	16.55	3.74	1.33	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	11.67	29.33	6.88	0.30	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	7.20	13.70	2.68	0.57	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	27.39	14.65	4.14	1.27	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	12.16	17.69	4.42	1.11	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	4.17	13.27	1.52	0.38	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	25.00	17.05	5.11	1.14	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	22.12	22.12	3.44	0.98	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	9.12	9.78	3.91	0.00	0.65
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	22.05	15.00	5.29	0.59	0.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	20.76	22.78	2.59	0.58	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	12.78	20.20	3.30	0.82	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	12.80	18.76	4.47	0.60	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	7.53	15.07	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	21.39	21.39	7.13	1.78	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	17.74	10.51	3.61	1.97	0.33
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	33.66	14.73	2.10	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	7.51	22.34	3.16	1.38	0.20
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	22.35	30.73	7.45	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	17.27	13.89	3.76	1.88	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	20.77	17.31	3.20	0.80	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	5.20	13.23	2.38	0.57	0.57
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	11.79	10.31	1.47	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	14.29	13.19	3.66	0.37	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	28.00	12.44	1.56	1.56	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	10.15	19.24	4.28	0.53	0.53
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	11.59	3.86	0.00	3.86	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	19.19	7.07	4.04	1.01	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	24.03	14.76	2.11	2.95	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	17.71	16.34	5.45	12.26	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	8.27	17.80	3.81	3.18	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	10.53	10.53	5.67	4.86	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	36.25	16.61	3.02	3.02	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	91.36	28.55	0.00	57.10	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	55.46	55.46	32.62	9.79	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	14.26	19.01	0.00	4.75	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	87.84	37.65	0.00	25.10	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	13.57	16.16	5.60	2.80	0.22
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	25.61	18.29	7.32	6.27	0.52
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	9.34	5.34	4.00	0.00	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	5.43	19.20	2.50	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	14.26	24.91	4.18	0.19	0.19
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	30.32	14.36	6.38	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	12.24	8.16	2.04	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	44.10	16.54	9.19	3.68	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	10.46	7.53	7.12	0.84	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	9.30	29.29	5.11	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	4.86	9.46	1.89	0.27	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	14.09	18.29	4.63	1.05	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	22.27	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	8.93	12.41	1.49	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	10.29	23.82	4.87	0.81	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	6.57	19.04	4.76	0.68	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	3.92	15.02	1.63	0.33	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	16.22	21.69	4.92	1.64	0.55
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	8.49	7.96	2.12	1.06	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	7.20	13.81	1.80	1.20	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	14.11	24.94	5.25	1.97	0.66
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	6.50	25.21	4.55	0.81	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	14.82	23.11	4.41	1.23	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	10.55	14.77	2.81	0.00	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	10.11	28.04	7.36	0.46	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	6.75	18.00	2.89	0.64	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	19.66	47.59	5.86	1.03	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	30.34	40.46	2.53	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	16.93	22.28	2.90	1.11	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	6.35	16.51	5.50	0.42	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	8.07	24.45	5.70	0.47	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	6.44	13.74	3.86	0.00	1.72
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	18.06	18.06	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	2.67	15.99	2.33	0.33	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	10.37	14.43	2.25	0.90	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	8.73	11.90	1.98	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	7.43	13.00	0.93	0.00	0.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	9.84	38.97	10.59	1.51	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	5.87	17.92	2.93	0.33	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	2.18	17.87	1.31	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	14.02	22.16	5.88	0.90	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	6.17	8.82	1.76	0.88	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	13.30	7.31	0.66	0.00	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	5.46	15.87	5.46	1.49	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	6.89	19.52	1.91	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	5.44	24.20	3.93	1.21	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	12.60	19.23	3.76	1.11	1.11
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	10.16	14.91	2.71	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	30.66	40.88	0.00	5.11	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	6.71	17.68	4.88	0.00	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	6.29	26.44	2.52	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	5.45	15.74	1.82	0.30	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	10.28	17.41	1.58	2.37	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	17.00	29.47	12.47	4.53	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	60.69	50.58	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	13.29	16.15	3.73	0.50	0.37
Myoblast, donor2	11322-117D8	22.44	13.04	1.73	1.34	0.19
Myoblast, donor3	11398-118D3	8.74	17.15	3.53	0.84	0.34
NK T cell leukemia cell line:KHYG-1	10777-110G3	32.11	21.16	13.57	1.75	0.88
Natural Killer Cells, donor1	11230-116C6	31.06	34.75	15.07	2.46	2.46
Natural Killer Cells, donor2	11311-117C6	68.15	38.00	13.57	2.71	2.71
Natural Killer Cells, donor3	11387-118C1	55.95	43.07	13.80	5.34	2.76
Neural stem cells, donor1	11275-116H6	19.96	8.35	1.81	2.18	0.36
Neural stem cells, donor2	11352-117H2	28.88	9.63	1.93	0.00	0.00
Neurons, donor1	11494-119E9	37.55	28.45	2.28	4.55	1.14
Neurons, donor2	11574-120E8	18.27	10.13	3.30	2.20	0.66
Neurons, donor3	11655-122E8	51.80	38.64	9.04	1.64	1.64
Neutrophils, donor1	11233-116C9	61.25	268.19	28.77	4.64	1.86
Neutrophils, donor2	11314-117C9	139.15	202.92	8.70	0.00	0.00
Neutrophils, donor3	11390-118C4	69.03	375.67	39.09	4.28	1.83
Nucleus Pulposus Cell, donor1	11252-116F1	10.92	23.98	2.97	1.07	0.12
Nucleus Pulposus Cell, donor2	11409-118E5	8.47	26.05	1.63	0.65	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	14.84	15.64	2.61	1.00	0.40
Olfactory epithelial cells, donor1	11933-125I7	33.31	16.11	7.02	1.38	0.55
Olfactory epithelial cells, donor2	11934-125I8	34.02	23.01	4.63	1.30	0.43
Olfactory epithelial cells, donor3	11935-125I9	31.33	15.21	5.45	2.61	0.34
Olfactory epithelial cells, donor4	11936-126A1	17.43	15.39	3.02	2.34	0.39
Oligodendrocyte - precursors, donor1	11496-119F2	21.06	7.82	5.42	1.81	0.00
Osteoblast - differentiated, donor1	11276-116H7	2.34	16.59	2.13	0.85	0.00
Osteoblast - differentiated, donor2	11353-117H3	3.43	10.29	1.14	1.14	0.00
Osteoblast - differentiated, donor3	11425-118G3	15.52	22.97	1.86	2.48	0.00
Osteoblast, donor1	11277-116H8	2.74	7.82	1.37	1.76	0.20
Osteoblast, donor2	11354-117H4	12.64	9.83	0.70	0.70	0.70
Osteoblast, donor3	11426-118G4	5.51	13.86	1.60	1.07	1.24
Pancreatic stromal cells, donor1	11249-116E7	16.17	11.54	2.70	0.76	0.08
Pericytes, donor1	11491-119E6	5.01	5.23	0.89	0.22	0.11
Pericytes, donor2	11571-120E5	14.94	9.28	2.04	1.13	0.00
Pericytes, donor3	11652-122E5	16.28	7.53	5.09	1.02	0.20
Perineurial Cells, donor1	11499-119F5	16.95	9.95	3.28	1.13	0.34
Perineurial Cells, donor2	11579-120F4	9.29	9.39	2.76	0.83	0.09
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	25.18	39.20	10.52	3.19	1.59
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	34.28	49.71	8.82	2.20	0.49
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	19.67	34.68	6.47	4.27	0.91
Placental Epithelial Cells, donor1	11278-116H9	5.50	10.52	2.87	1.67	0.00
Placental Epithelial Cells, donor2	11355-117H5	5.54	3.33	6.65	1.11	0.00
Placental Epithelial Cells, donor3	11427-118G5	5.69	7.26	1.57	2.36	0.59
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	11.71	18.67	9.49	1.90	0.00
Preadipocyte - breast, donor1	11467-119B9	12.01	21.38	3.19	1.50	0.38
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	10.05	10.18	5.61	1.70	0.52
Preadipocyte - breast, donor2	11328-117E5	29.04	15.76	7.20	0.90	0.68
Preadipocyte - omental, donor1	11468-119C1	22.06	11.19	12.79	2.45	0.32
Preadipocyte - omental, donor2	11329-117E6	15.28	24.88	7.42	0.44	0.44
Preadipocyte - omental, donor3	11403-118D8	26.36	23.06	5.30	1.72	0.14
Preadipocyte - perirenal, donor1	11469-119C2	14.76	14.76	2.95	0.98	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	2.15	10.75	2.46	0.31	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	29.75	11.16	2.30	0.89	0.18
Preadipocyte - subcutaneous, donor3	11428-118G6	14.30	22.82	2.72	0.85	0.34
Preadipocyte - visceral, donor1	11280-116I2	11.27	13.04	3.17	1.02	0.09
Preadipocyte - visceral, donor2	11357-117H7	22.55	11.04	2.76	0.00	0.00
Preadipocyte - visceral, donor3	11429-118G7	24.66	10.34	2.61	0.84	0.10
Prostate Epithelial Cells (polarized), donor1	11253-116F2	26.85	14.18	3.92	2.72	1.06
Prostate Epithelial Cells, donor2	11331-117E8	15.17	13.27	2.17	0.27	0.27
Prostate Epithelial Cells, donor3	11404-118D9	13.66	18.13	3.86	1.84	0.24
Prostate Stromal Cells, donor1	11254-116F3	19.59	9.57	2.73	1.03	0.23
Prostate Stromal Cells, donor2	11332-117E9	32.45	10.76	2.87	0.72	0.18
Prostate Stromal Cells, donor3	11405-118E1	23.25	17.00	2.92	1.88	0.42
Renal Cortical Epithelial Cells, donor1	11516-119H4	4.01	11.31	2.92	0.73	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	17.33	13.38	3.40	2.15	0.62
Renal Epithelial Cells, donor1	11517-119H5	4.57	1.01	2.03	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	14.23	9.25	0.00	0.71	0.71
Renal Epithelial Cells, donor3	11678-122H4	16.09	10.27	2.86	1.91	0.21
Renal Glomerular Endothelial Cells, donor1	11514-119H2	16.34	5.45	0.68	2.04	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	19.68	9.43	3.37	2.16	0.13
Renal Glomerular Endothelial Cells, donor3	11675-122H1	30.86	11.54	5.33	1.55	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	4.66	2.66	0.00	2.66	0.00
Renal Mesangial Cells, donor1	11518-119H6	6.38	7.48	1.54	1.54	0.44
Renal Mesangial Cells, donor2	11598-120H5	11.91	9.40	4.39	1.88	0.63
Renal Mesangial Cells, donor3	11679-122H5	3.61	3.05	1.66	0.83	0.83
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	11.81	9.93	3.49	1.07	0.54
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	14.76	6.33	2.53	1.69	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	13.50	8.87	3.09	0.96	0.19
Retinal Pigment Epithelial Cells, donor0	11215-116A9	18.41	11.93	3.63	0.26	1.04
Retinal Pigment Epithelial Cells, donor1	11528-119I7	9.38	9.95	2.84	0.85	0.57
Retinal Pigment Epithelial Cells, donor2	11608-120I6	8.23	3.09	0.00	1.03	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	16.81	6.02	3.01	1.00	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	27.53	37.28	9.49	4.41	0.67
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	8.04	8.04	4.47	0.89	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	13.76	9.36	2.20	9.36	1.65
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	12.18	12.18	4.06	4.06	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	18.07	8.58	4.55	2.47	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	16.29	6.65	3.08	2.58	1.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	13.83	5.13	2.12	3.57	1.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	22.20	4.22	3.60	3.60	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	19.00	5.71	3.15	3.50	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	18.95	9.25	3.93	3.24	1.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	13.96	5.89	1.92	2.60	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	14.98	4.24	3.78	2.42	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	10.57	7.71	3.40	3.76	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	17.21	5.45	1.43	2.73	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	16.20	5.04	2.79	3.43	1.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	16.82	7.30	3.10	2.21	0.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	11.09	4.59	2.68	3.44	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	17.24	6.15	3.17	2.14	0.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	11.09	4.89	3.01	3.01	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	16.59	6.50	3.05	3.18	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	12.95	8.37	3.31	2.04	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	14.70	7.45	2.86	2.86	1.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	14.10	6.30	2.88	2.35	0.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	17.10	4.20	2.52	2.24	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	17.09	4.79	2.05	2.39	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	15.68	5.65	2.92	2.73	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	16.31	6.87	2.58	2.45	0.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	16.79	9.13	2.55	3.36	1.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	12.97	6.84	2.12	5.66	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	16.87	8.53	2.78	3.17	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	18.01	5.38	4.44	1.40	2.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	14.93	3.73	2.49	2.49	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	23.45	8.41	1.11	1.55	0.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	14.83	8.77	3.76	3.55	1.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	16.55	6.06	2.42	3.50	0.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	15.33	4.94	4.60	1.70	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	15.23	8.29	3.47	3.47	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	11.18	6.36	2.58	3.61	0.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	13.17	6.86	4.80	2.47	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	19.04	7.06	3.12	1.81	0.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	10.40	5.11	2.73	2.39	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	12.87	5.33	2.66	1.48	1.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	11.73	7.73	1.87	1.60	1.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	20.05	7.05	2.77	3.87	0.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	19.76	7.14	3.81	2.62	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	10.88	9.47	3.63	1.61	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	16.86	5.56	2.83	3.77	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	12.93	6.99	3.84	4.54	1.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	12.39	9.07	1.81	2.42	1.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	13.83	5.02	2.81	3.18	1.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	23.29	13.10	4.66	6.99	2.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	21.90	10.34	3.65	1.22	3.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	12.36	4.22	2.41	2.41	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	15.15	10.63	5.20	3.85	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	17.97	7.79	2.70	5.69	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	12.87	8.15	5.31	3.07	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	8.75	11.95	3.63	1.92	1.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	18.63	18.03	6.01	4.81	1.80
Schwann Cells, donor1	11498-119F4	10.91	5.64	1.50	0.56	0.38
Schwann Cells, donor2	11578-120F3	27.22	17.01	13.61	3.40	0.00
Schwann Cells, donor3	11659-122F3	24.98	7.23	1.75	1.31	0.44
Sebocyte, donor1	11220-116B5	9.86	9.86	4.38	0.55	0.00
Sebocyte, donor2	11301-117B5	8.27	9.65	0.46	0.92	0.46
Sebocyte, donor3	11378-118B1	7.63	10.31	1.03	1.24	0.21
Sertoli Cells, donor1	11255-116F4	14.91	19.88	3.31	4.97	0.00
Sertoli Cells, donor2	11333-117F1	33.89	16.95	0.00	5.65	0.00
Skeletal Muscle Cells, donor1	11281-116I3	9.50	7.57	2.46	2.73	0.53
Skeletal Muscle Cells, donor2	11358-117H8	0.72	11.57	0.00	1.45	0.72
Skeletal Muscle Cells, donor3	11430-118G8	4.18	9.20	0.84	3.34	0.00
Skeletal Muscle Cells, donor4	11451-119A2	25.45	8.80	2.20	0.79	0.00
Skeletal Muscle Cells, donor5	11455-119A6	22.45	11.45	2.38	1.49	0.15
Skeletal Muscle Cells, donor6	11459-119B1	25.24	13.08	4.62	0.92	0.31
Skeletal Muscle Satellite Cells, donor1	11240-116D7	13.10	9.95	2.27	1.51	0.25
Skeletal Muscle Satellite Cells, donor2	11321-117D7	18.26	9.13	2.71	0.29	0.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	19.74	12.70	3.37	1.79	0.89
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	7.16	8.34	2.53	1.52	0.51
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	5.07	4.34	1.45	1.45	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	5.09	6.19	0.69	0.83	0.14
Skin - palm, donor1	10286-104F7	5.37	42.98	26.86	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	2.59	10.24	1.87	1.01	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	6.54	21.27	6.54	3.27	0.82
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	6.62	7.01	2.99	0.65	0.13
Small Airway Epithelial Cells, donor1	11256-116F5	22.80	15.15	5.42	0.83	0.70
Small Airway Epithelial Cells, donor2	11334-117F2	20.54	17.16	4.64	0.56	0.14
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	10.78	19.66	1.48	7.19	1.27
Small Airway Epithelial Cells, donor3	11406-118E2	16.64	25.41	4.42	2.47	0.52
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	12.03	7.71	3.09	1.54	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	11.34	7.56	4.45	2.00	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	3.53	12.34	3.53	2.35	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	9.28	12.15	14.14	0.88	0.22
Smooth Muscle Cells - Aortic, donor2	11360-117I1	3.15	14.57	1.97	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	6.18	16.22	2.32	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	14.01	9.01	4.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	2.66	11.05	4.79	0.80	0.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	37.02	15.52	4.65	0.66	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	13.83	18.05	7.17	0.77	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	15.30	6.51	1.63	0.33	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	9.45	20.08	1.77	1.18	0.59
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	11.25	9.11	6.55	0.85	0.28
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	8.46	6.67	1.63	0.65	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	16.44	17.35	3.65	0.91	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	4.04	11.87	2.27	1.01	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	48.97	18.36	12.24	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	5.72	6.68	1.91	0.95	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	11.21	5.90	2.21	0.74	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	17.65	10.33	1.72	1.08	0.65
Smooth Muscle Cells - Colonic, donor3	11396-118D1	13.75	10.71	2.73	1.05	0.10
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	4.02	17.32	2.78	0.77	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	2.16	15.09	1.08	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	8.97	11.06	2.39	1.20	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	7.17	4.78	1.02	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	13.19	9.97	2.20	2.20	0.31
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	13.49	18.72	4.33	1.41	0.40
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	44.15	23.89	9.78	1.37	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	7.85	7.25	1.81	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	14.04	8.48	4.50	1.59	0.53
Smooth Muscle Cells - Prostate, donor1	11257-116F6	31.56	11.85	5.33	1.33	0.53
Smooth Muscle Cells - Prostate, donor2	11335-117F3	27.17	7.64	1.25	0.88	0.13
Smooth Muscle Cells - Prostate, donor3	11465-119B7	8.88	14.21	2.54	0.25	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	10.70	14.02	3.02	0.75	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	6.00	15.75	3.75	0.75	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	25.84	33.60	95.62	1.29	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	2.79	9.77	2.79	0.93	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	26.76	8.58	6.06	1.01	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	15.36	12.54	6.89	0.00	0.63
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	4.42	6.49	1.18	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	13.66	8.16	2.83	1.17	0.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	17.28	7.94	2.34	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	3.31	16.12	4.17	1.44	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	8.16	15.81	2.04	0.76	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	5.26	8.84	3.01	0.75	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	12.16	9.36	1.68	0.98	0.14
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	13.24	10.47	2.09	0.59	0.34
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	3.33	3.81	1.43	0.00	0.48
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	2.69	16.64	4.16	0.73	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	27.18	13.26	7.29	1.33	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	16.09	12.29	7.31	0.29	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	15.74	15.55	3.50	2.33	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	16.93	6.35	3.17	0.26	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	21.20	14.51	3.72	1.12	1.49
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	11.86	27.31	7.55	2.52	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	16.18	15.05	5.39	1.14	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	19.30	19.69	3.54	2.76	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	14.98	14.98	4.32	1.02	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	23.56	22.36	4.79	2.40	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	19.23	28.01	2.93	2.51	0.84
Smooth muscle cells - airway, control, donor4	11969-126D7	26.13	28.42	5.04	2.75	0.00
Synoviocyte, donor1	11291-117A4	22.22	16.83	4.71	2.19	0.50
Synoviocyte, donor2	11368-117I9	33.52	19.44	3.86	1.01	0.00
Synoviocyte, donor3	11440-118H9	40.44	18.77	3.13	2.68	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	9.65	4.65	6.43	1.79	0.36
Trabecular Meshwork Cells, donor2	11612-122A1	7.93	5.95	3.96	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	6.02	2.78	1.16	0.93	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	5.02	12.33	2.22	1.00	0.22
Tracheal Epithelial Cells, donor2	11369-118A1	3.09	7.73	1.93	0.39	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	5.15	3.44	0.57	1.72	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	23.99	43.18	11.44	4.43	0.37
Urethra, donor2	10319-105A4	30.57	46.76	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	10.10	9.03	3.45	0.80	0.00
Urothelial Cells, donor2	11600-120H7	5.61	4.01	2.00	1.60	0.00
Urothelial Cells, donor3	11681-122H7	6.19	5.27	0.92	1.60	0.00
Urothelial cells, donor0	11216-116B1	23.63	13.15	4.24	0.67	0.22
Whole blood (ribopure), donor090309, donation1	12179-129A1	92.54	235.79	27.58	2.67	3.56
Whole blood (ribopure), donor090309, donation2	12180-129A2	85.78	288.78	38.60	2.86	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	59.55	175.24	15.74	0.68	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	54.75	94.00	10.67	3.44	0.69
Whole blood (ribopure), donor090325, donation2	12177-128I8	63.91	85.99	13.36	2.91	1.16
Whole blood (ribopure), donor090612, donation1	12182-129A4	71.85	236.36	35.40	3.12	1.04
Whole blood (ribopure), donor090612, donation2	12183-129A5	72.51	242.30	28.45	3.67	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	69.38	163.41	12.78	2.74	2.74
Wilms' tumor cell line:G-401	10809-111A8	28.99	10.61	5.06	1.11	0.62
Wilms' tumor cell line:HFWT	10597-108E3	19.36	14.96	5.28	1.76	0.88
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	28.21	14.25	5.59	0.56	0.84
achilles tendon, donor2	10292-104G4	66.13	53.73	16.53	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	28.05	14.02	8.41	1.27	0.25
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	31.34	15.56	3.48	4.64	2.55
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	21.72	12.35	4.75	6.17	1.90
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	27.21	18.50	6.80	4.08	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	15.46	3.09	1.97	0.56	0.28
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	5.08	7.61	2.11	1.06	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	18.24	16.60	2.99	1.36	0.27
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	24.68	16.30	3.97	2.20	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	21.23	17.97	2.04	2.45	1.23
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	23.69	21.36	4.27	3.88	0.78
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	20.98	9.02	2.02	1.84	0.37
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	19.50	42.91	7.80	7.80	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	23.01	16.27	3.72	1.39	0.46
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	27.44	17.61	2.85	4.66	0.52
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	20.46	14.03	1.75	3.51	0.58
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	14.41	13.01	0.93	1.39	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	22.21	9.87	2.88	1.65	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	10.74	10.13	7.06	0.92	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	18.35	19.63	5.12	1.28	0.85
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	18.50	18.50	3.94	2.12	1.21
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	16.37	14.92	4.81	1.20	0.48
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	8.02	6.46	1.78	0.67	0.45
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	16.01	13.01	3.67	0.67	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	14.87	13.01	5.57	1.86	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	7.16	22.98	2.64	1.13	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	12.21	11.78	3.49	3.49	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	11.25	7.50	5.62	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	22.84	45.92	10.13	3.53	0.47
adipose tissue, adult, pool1	10010-101C1	14.58	19.23	3.57	2.33	0.31
adipose, donor1	10184-103D4	77.41	26.97	0.59	2.93	1.76
adipose, donor2	10185-103D5	43.80	22.71	4.46	0.00	0.41
adipose, donor3	10186-103D6	46.56	20.42	3.27	4.08	0.54
adipose, donor4	10187-103D7	117.01	49.40	32.94	6.07	4.33
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	9.94	19.25	3.31	0.32	0.32
adrenal gland, adult, pool1	10081-102A9	21.83	40.01	14.55	7.28	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	13.74	13.47	3.07	1.87	0.40
alveolar cell carcinoma cell line:SW 1573	10708-109H6	62.53	21.08	8.58	6.07	1.07
amniotic membrane cells, donor1	12235-129G3	16.00	48.46	6.72	3.48	1.16
amniotic membrane cells, donor2	12236-129G4	21.30	43.62	8.79	3.72	0.00
amniotic membrane cells, donor3	12237-129G5	33.58	27.40	3.83	3.54	0.59
amygdala - adult, donor10196	10167-103B5	47.43	32.02	14.23	3.56	0.00
amygdala, adult, donor10252	10151-102I7	40.55	34.88	6.69	5.68	1.22
amygdala, newborn, donor10223	10360-105E9	29.69	30.02	11.94	3.55	0.97
anaplastic carcinoma cell line:8305C	10428-106D5	14.01	14.13	3.82	3.82	0.76
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	29.34	26.47	2.87	3.75	0.66
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	37.08	22.38	3.67	4.34	2.34
aorta, adult, pool1	10052-101G7	27.07	35.50	6.28	1.77	0.20
appendix, adult	10189-103D9	13.97	20.96	3.49	1.94	1.94
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	49.87	26.83	5.85	5.85	1.72
artery, adult	10190-103E1	110.05	66.58	14.95	2.72	0.00
astrocytoma cell line:TM-31	10425-106D2	25.06	8.11	5.79	1.59	0.87
b cell line:RPMI1788	10427-106D4	14.72	16.06	2.68	1.64	1.34
basal cell carcinoma cell line:TE 354.T	10702-109G9	19.42	30.52	13.59	1.11	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	13.79	19.05	2.98	4.56	1.39
bile duct carcinoma cell line:TFK-1	10496-107C1	8.70	6.86	1.84	1.84	0.33
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	20.13	20.69	5.59	4.47	0.56
bladder, adult, pool1	10011-101C2	19.23	29.88	4.89	3.37	0.33
blood, adult, pool1	10053-101G8	68.65	90.80	22.15	2.21	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	14.56	12.85	4.28	0.00	0.00
bone marrow, adult	10192-103E3	10.80	18.22	2.70	1.35	0.00
brain, adult, donor1	10084-102B3	26.65	17.43	8.20	5.13	0.00
brain, adult, pool1	10012-101C3	18.04	23.72	6.90	1.78	0.56
brain, fetal, pool1	10085-102B4	21.37	34.73	8.01	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	58.47	28.08	6.61	2.97	0.33
breast carcinoma cell line:MDA-MB-453	10419-106C5	13.98	11.11	3.00	2.87	0.12
breast, adult, donor1	10080-102A8	10.73	37.25	6.94	1.26	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	17.40	9.78	1.40	0.38	0.38
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	23.50	15.46	2.16	0.62	0.62
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	13.35	3.91	0.46	0.46	0.46
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	46.96	29.29	8.23	2.91	0.97
carcinoid cell line:NCI-H1770	10703-109H1	37.14	12.69	6.58	3.29	1.41
carcinoid cell line:NCI-H727	10735-110B6	16.19	20.24	5.58	0.98	0.33
carcinoid cell line:SK-PN-DW	10719-109I8	41.20	11.41	4.75	9.51	2.54
carcinosarcoma cell line:JHUCS-1	10642-109A3	43.39	22.09	2.66	4.53	3.73
caudate nucleus - adult, donor10196	10177-103C6	33.39	32.24	9.21	3.45	0.00
caudate nucleus, adult, donor10252	10164-103B2	25.10	28.28	4.52	3.18	1.17
caudate nucleus, adult, donor10258	10379-105H1	22.92	22.16	5.35	1.53	1.53
caudate nucleus, newborn, donor10223	10354-105E3	33.69	43.22	11.72	6.59	1.83
cerebellum - adult, donor10196	10173-103C2	34.96	78.66	17.48	14.57	0.00
cerebellum, adult, donor10252	10166-103B4	25.41	42.70	6.83	8.54	1.71
cerebellum, adult, pool1	10083-102B2	31.05	38.29	11.73	1.72	1.03
cerebellum, newborn, donor10223	10357-105E6	26.57	88.01	9.96	5.81	0.00
cerebral meninges, adult	10188-103D8	26.98	28.74	13.87	4.54	1.01
cerebrospinal fluid, donor2	10294-104G6	72.36	57.74	11.69	2.19	0.00
cervical cancer cell line:D98-AH2	10552-107I3	17.83	22.86	8.77	2.73	0.72
cervical cancer cell line:ME-180	10553-107I4	22.54	27.01	6.96	0.99	0.50
cervix, adult, pool1	10013-101C4	18.06	22.15	3.57	2.94	0.63
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	23.41	26.89	11.29	5.85	0.42
chondrosarcoma cell line:SW 1353	10700-109G7	6.53	10.45	6.53	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	27.84	15.04	5.72	6.96	2.11
choriocarcinoma cell line:SCH	10785-110H2	53.35	18.36	7.76	3.33	0.74
choriocarcinoma cell line:T3M-3	10618-108G6	11.62	5.46	1.66	1.19	0.00
chorionic membrane cells, donor1	12238-129G6	12.25	30.77	8.26	3.13	1.71
chorionic membrane cells, donor2	12239-129G7	20.18	18.59	6.56	2.39	0.30
chorionic membrane cells, donor3	12240-129G8	22.53	20.33	4.95	2.75	1.65
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	19.19	10.10	6.06	4.04	1.01
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	26.32	21.52	5.19	0.96	0.77
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	20.70	23.65	5.70	0.42	0.84
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	18.75	10.02	2.57	2.57	0.26
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	18.62	8.47	6.05	2.18	0.48
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	20.16	9.16	4.89	2.44	1.63
chronic myelogenous leukemia cell line:K562	10454-106G4	26.80	12.07	7.07	1.77	0.29
chronic myelogenous leukemia cell line:KU812	10409-106B4	12.25	10.43	2.61	1.82	0.26
clear cell carcinoma cell line:JHOC-5	10638-108I8	26.52	16.46	2.74	0.46	0.46
clear cell carcinoma cell line:TEN	10636-108I6	23.42	28.11	5.21	4.16	0.69
colon carcinoma cell line:CACO-2	10513-107D9	21.23	13.73	4.03	1.46	0.18
colon carcinoma cell line:COLO-320	10420-106C6	30.79	7.60	3.04	3.80	1.90
colon, adult, donor1	10082-102B1	21.42	39.27	3.57	0.00	0.00
colon, adult, pool1	10014-101C5	16.33	39.36	7.29	3.88	0.71
colon, fetal, donor1	10070-101I7	46.35	61.18	9.27	3.71	1.85
common myeloid progenitor CMP, donor1	12130-128D6	22.92	9.17	9.17	4.58	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	25.04	50.07	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	96.46	29.32	90.09	4.67	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	51.92	16.60	46.03	3.62	1.81
cord blood derived cell line:COBL-a untreated	10449-106F8	55.42	14.10	41.74	2.12	0.14
corpus callosum, adult, pool1	10042-101F6	10.95	20.56	2.76	2.32	0.44
cruciate ligament, donor2	10295-104G7	39.71	62.41	10.54	1.62	0.81
diaphragm, fetal, donor1	10069-101I6	65.81	49.76	14.45	1.61	0.00
diencephalon, adult	10193-103E4	27.60	21.36	5.04	1.20	0.48
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	31.46	14.24	4.13	1.84	0.69
ductal cell carcinoma cell line:KLM-1	10438-106E6	17.69	16.16	5.39	0.77	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	30.57	24.79	11.55	0.00	0.24
ductus deferens, adult	10196-103E7	19.93	15.95	2.49	2.49	0.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	46.09	30.24	10.08	2.88	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	35.31	24.28	5.89	2.94	0.74
dura mater, adult, donor1	10041-101F5	19.82	17.43	7.02	0.74	0.00
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	35.09	9.77	11.99	4.44	0.22
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	27.08	10.03	4.44	2.72	0.72
embryonic pancreas cell line:1B2C6	10604-108F1	24.66	18.50	7.40	1.85	1.23
embryonic pancreas cell line:1C3D3	10605-108F2	15.14	16.35	4.54	1.21	0.61
embryonic pancreas cell line:1C3IKEI	10606-108F3	17.60	20.69	6.79	1.85	0.00
embryonic pancreas cell line:2C6	10603-108E9	30.21	14.45	6.57	1.31	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	21.79	12.40	4.69	1.68	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	28.45	37.70	7.97	3.81	1.09
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	29.27	23.48	3.86	1.45	0.96
epidermoid carcinoma cell line:A431	10426-106D3	23.34	16.78	10.34	3.22	0.56
epidermoid carcinoma cell line:Ca Ski	10431-106D8	6.27	8.69	4.29	0.99	0.11
epididymis, adult	10197-103E8	27.00	21.77	7.95	2.30	0.63
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	25.55	17.39	7.10	1.60	0.53
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	29.10	8.26	2.75	1.97	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	27.78	15.59	3.28	2.62	1.05
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	30.81	22.14	4.13	4.43	0.89
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	26.44	17.70	3.47	1.90	0.56
esophagus, adult, pool1	10015-101C6	14.97	28.99	4.57	1.91	0.53
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	24.42	19.66	7.01	4.88	1.25
eye - muscle inferior rectus, donor1	10272-104E2	101.41	77.27	16.90	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	122.04	69.44	23.15	0.00	0.00
eye - muscle medial, donor2	10299-104H2	69.95	104.18	16.37	1.49	0.00
eye - muscle superior, donor2	10297-104G9	43.57	50.45	14.90	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	42.26	23.32	8.74	1.46	0.00
eye, fetal, donor1	10054-101G9	27.71	32.03	8.90	2.29	0.51
fibrosarcoma cell line:HT-1080	10758-110E2	16.28	16.03	4.23	1.80	1.15
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	74.79	32.76	6.17	2.14	0.47
frontal lobe, adult, pool1	10040-101F4	18.11	26.27	12.01	2.81	0.75
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	22.82	24.92	5.10	1.50	0.60
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	7.95	13.35	3.66	2.01	0.37
gall bladder, adult	10198-103E9	16.42	20.52	4.35	1.69	0.48
gamma delta positive T cells, donor1	11937-126A2	18.25	32.75	4.83	6.98	2.15
gamma delta positive T cells, donor2	11938-126A3	21.29	31.75	11.58	1.12	3.36
gastric adenocarcinoma cell line:MKN1	10614-108G2	21.54	17.11	4.65	4.22	1.27
gastric adenocarcinoma cell line:MKN45	10612-108F9	19.92	14.12	6.19	3.48	1.16
gastric cancer cell line:AZ521	10549-107H9	25.41	16.07	6.23	2.79	0.98
gastric cancer cell line:GSS	10560-108A2	31.12	14.64	0.92	3.66	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	50.72	15.08	4.57	2.51	0.69
giant cell carcinoma cell line:LU65	10487-107B1	32.59	24.21	6.31	3.90	0.69
giant cell carcinoma cell line:Lu99B	10433-106E1	18.61	20.71	5.60	1.40	0.56
glassy cell carcinoma cell line:HOKUG	10688-109F4	18.21	13.22	2.99	3.24	1.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	18.37	10.56	6.76	2.96	1.27
glioblastoma cell line:A172, tech_rep2	10444-106F3	22.75	12.92	10.11	4.07	0.70
glioblastoma cell line:T98G	10485-107A8	23.18	15.34	5.63	2.65	0.33
glioma cell line:GI-1	10413-106B8	11.13	3.81	3.51	2.05	1.76
globus pallidus - adult, donor10196	10175-103C4	30.61	34.26	5.83	1.46	0.00
globus pallidus, adult, donor10252	10161-103A8	29.54	37.83	1.71	4.64	0.73
globus pallidus, adult, donor10258	10367-105F7	45.18	31.49	6.85	1.37	0.00
globus pallidus, newborn, donor10223	10364-105F4	19.19	23.45	6.40	4.80	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	17.13	36.71	2.45	0.00	2.45
granulocyte macrophage progenitor, donor2	12135-128E2	10.93	10.93	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	10.45	20.91	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	18.24	24.64	7.04	1.60	0.32
hIPS +CCl2, biol_rep1	14383-156B9	33.06	10.56	9.18	2.75	0.46
hIPS +CCl2, biol_rep2	14384-156C1	32.01	10.52	8.23	1.83	0.00
hIPS +CCl2, biol_rep3	14385-156C2	50.24	9.02	6.44	4.51	0.64
hIPS, biol_rep1	14380-156B6	43.12	7.19	12.94	1.44	0.00
hIPS, biol_rep2	14381-156B7	43.90	7.54	9.60	0.00	0.69
hIPS, biol_rep3	14382-156B8	34.21	30.90	7.72	3.31	0.00
hairy cell leukemia cell line:Mo	10712-109I1	34.19	14.37	5.17	1.44	2.01
heart - mitral valve, adult	10205-103F7	48.13	46.94	15.55	2.39	0.60
heart - pulmonic valve, adult	10206-103F8	31.90	37.39	5.75	1.57	0.26
heart - tricuspid valve, adult	10207-103F9	38.30	71.61	9.16	4.16	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	40.00	36.93	9.18	0.61	0.00
heart, adult, diseased, donor1	10051-101G6	68.98	55.36	12.35	1.28	0.00
heart, adult, pool1	10016-101C7	55.19	94.29	34.73	3.45	0.23
heart, fetal, pool1	10046-101G1	40.76	43.43	10.58	4.00	0.00
hepatic mesenchymal tumor cell line:LI90	10778-110G4	28.69	24.99	20.36	1.23	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	40.43	13.08	8.32	2.38	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	52.38	13.92	3.87	3.20	1.88
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	47.09	14.44	3.16	2.91	0.85
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	45.78	13.04	4.24	3.74	1.01
hepatoma cell line:Li-7	10484-107A7	34.25	16.35	15.13	3.34	0.44
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	19.80	16.18	4.12	4.12	1.11
hippocampus - adult, donor10196	10169-103B7	43.53	38.80	13.25	4.73	0.00
hippocampus, adult, donor10252	10153-102I9	29.80	33.47	4.90	2.86	1.43
hippocampus, adult, donor10258	10374-105G5	35.35	24.40	15.93	3.98	0.50
hippocampus, newborn, donor10223	10363-105F3	22.56	31.72	9.87	1.76	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	48.22	17.09	2.44	9.16	2.44
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	29.45	8.25	2.95	4.32	1.96
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	22.34	8.63	2.29	4.32	2.03
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	33.83	5.07	2.82	2.82	1.13
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	40.28	5.68	2.58	1.03	1.29
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	29.61	5.31	0.76	1.52	1.14
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	43.50	9.05	3.50	2.63	2.92
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	38.13	11.42	2.15	1.72	4.09
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	39.20	10.43	3.75	2.50	2.92
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	26.52	11.84	2.84	1.42	1.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	45.00	9.32	1.61	2.57	1.45
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	30.30	10.77	3.37	2.02	1.35
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	18.62	8.92	0.63	3.91	2.50
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	32.43	13.26	1.97	4.42	2.95
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	31.42	13.96	0.87	4.36	4.36
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	32.45	11.26	2.29	2.10	1.34
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	35.76	8.29	1.74	0.44	1.31
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	39.48	14.99	1.00	2.00	1.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	33.91	13.75	2.64	0.94	0.57
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	43.65	19.55	3.18	0.91	1.36
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	44.48	14.41	1.88	2.51	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	34.95	13.06	2.45	1.47	1.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	33.39	11.90	3.77	2.32	0.58
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	33.18	14.35	3.59	2.09	0.90
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	24.02	7.57	2.96	4.43	2.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	25.68	14.26	3.14	3.42	2.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	56.35	6.12	4.08	3.27	3.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	32.39	8.10	0.70	3.17	1.06
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	27.87	6.97	2.22	0.63	0.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	23.00	6.96	3.33	1.82	0.91
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	21.20	12.93	7.24	2.07	1.55
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	32.54	9.96	2.66	0.66	1.33
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	24.63	11.80	1.80	2.82	1.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	30.42	10.23	2.05	1.53	0.77
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	40.13	13.63	1.51	0.00	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	39.99	15.12	3.70	1.68	0.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	31.15	8.94	3.38	5.80	1.69
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	41.00	8.02	4.90	4.46	0.89
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	38.54	9.27	1.95	9.76	1.95
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	28.73	8.86	1.22	1.83	1.22
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	130.13	9.76	6.51	6.51	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	39.71	6.95	2.32	2.65	0.99
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	35.03	14.78	0.00	3.28	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	30.04	11.58	3.26	2.17	1.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	31.32	11.03	3.20	2.85	2.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	44.16	13.13	2.39	2.39	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	26.00	9.34	2.30	2.30	0.81
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	38.52	10.24	3.77	2.69	0.27
immature langerhans cells, donor1	11904-125F5	21.55	34.38	10.17	1.70	0.24
immature langerhans cells, donor2	11905-125F6	17.43	50.70	7.92	3.96	3.96
insula, adult, pool1	10039-101F3	16.94	25.65	11.92	4.73	1.23
keratoacanthoma cell line:HKA-1	10791-110H8	23.09	21.46	8.13	1.63	0.33
kidney, adult, pool1	10017-101C8	14.22	16.92	4.31	2.30	0.50
kidney, fetal, pool1	10045-101F9	14.50	22.14	4.24	2.48	0.14
large cell lung carcinoma cell line:IA-LM	10509-107D5	19.17	27.55	8.38	4.54	1.56
large cell lung carcinoma cell line:NCI-H460	10839-111E2	23.22	12.44	6.50	2.49	0.97
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	28.26	20.18	4.77	1.10	1.28
left atrium, adult, donor1	10079-102A7	40.32	39.23	13.08	0.54	0.54
left ventricle, adult, donor1	10078-102A6	86.47	62.70	14.16	2.53	0.51
leiomyoblastoma cell line:G-402	10721-110A1	16.69	10.67	3.56	0.55	0.27
leiomyoma cell line:10964C	10569-108B2	16.53	24.07	3.95	0.36	0.36
leiomyoma cell line:15242A	10570-108B3	19.57	10.87	2.17	1.09	0.00
leiomyoma cell line:15425	10571-108B4	15.30	15.05	2.19	0.73	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	6.35	6.35	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	15.68	21.96	9.41	3.14	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	47.58	35.89	13.69	1.77	0.47
liposarcoma cell line:KMLS-1	10782-110G8	13.75	19.68	5.00	1.25	0.31
liposarcoma cell line:SW 872	10726-110A6	17.54	10.48	3.17	0.73	0.49
liver, adult, pool1	10018-101C9	11.99	13.61	5.02	1.13	0.16
liver, fetal, pool1	10086-102B5	19.75	30.10	12.23	1.88	0.00
locus coeruleus - adult, donor10196	10182-103D2	20.42	25.37	3.94	2.04	0.29
locus coeruleus, adult, donor10252	10165-103B3	26.76	29.34	4.24	3.32	1.29
locus coeruleus, adult, donor10258	10375-105G6	23.14	25.39	8.46	3.10	0.00
locus coeruleus, newborn, donor10223	10362-105F2	20.19	26.50	5.05	4.63	0.42
lung adenocarcinoma cell line:A549	10499-107C4	16.33	13.15	6.78	1.38	0.14
lung adenocarcinoma cell line:PC-14	10408-106B3	10.34	8.27	2.76	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	12.39	15.03	2.11	0.66	0.13
lung, adult, pool1	10019-101D1	14.88	31.89	5.20	1.89	0.35
lung, fetal, donor1	10068-101I5	35.68	83.91	17.98	7.71	0.86
lung, right lower lobe, adult, donor1	10075-102A3	29.78	45.82	9.16	0.92	1.37
lymph node, adult, donor1	10077-102A5	15.15	23.19	8.05	0.47	1.42
lymphangiectasia cell line:DS-1	10727-110A7	29.15	26.30	12.05	1.10	0.22
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	141.27	84.97	29.13	4.68	3.32
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	14.44	19.54	7.65	0.85	0.00
mature adipocyte, donor1	12231-129F8	17.32	34.19	7.55	1.33	0.44
mature adipocyte, donor2	12232-129F9	23.24	28.43	4.57	1.04	0.21
mature adipocyte, donor3	12233-129G1	13.75	19.68	4.27	1.42	0.95
mature adipocyte, donor4	12234-129G2	29.74	29.22	4.21	1.84	0.26
maxillary sinus tumor cell line:HSQ-89	10414-106B9	14.77	24.78	8.34	2.62	0.24
medial frontal gyrus - adult, donor10196	10170-103B8	30.46	45.12	22.56	4.51	1.13
medial frontal gyrus, adult, donor10252	10150-102I6	27.40	29.43	8.28	3.68	1.29
medial frontal gyrus, adult, donor10258	10368-105F8	33.04	28.59	15.57	4.45	0.95
medial frontal gyrus, newborn, donor10223	10352-105E1	53.31	45.21	13.22	5.97	1.71
medial temporal gyrus - adult, donor10196	10183-103D3	28.86	42.02	10.97	3.71	1.86
medial temporal gyrus, adult, donor10252	10156-103A3	31.62	32.89	6.79	6.37	0.85
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	55.86	15.41	7.71	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	71.77	14.35	14.35	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	36.61	33.02	9.69	6.46	2.15
medulla oblongata - adult, donor10196	10174-103C3	26.61	46.73	11.68	1.95	0.00
medulla oblongata, adult, donor10252	10155-103A2	18.11	22.60	3.25	3.87	1.39
medulla oblongata, adult, pool1	10038-101F2	10.37	17.71	5.22	2.53	0.33
medulla oblongata, newborn, donor10223	10361-105F1	25.00	29.51	6.25	2.08	0.69
medulloblastoma cell line:D283 Med	10838-111E1	33.43	13.51	3.32	9.74	2.88
medulloblastoma cell line:ONS-76	10759-110E3	33.63	12.35	9.78	1.59	0.12
melanoma cell line:COLO 679	10514-107E1	14.95	6.04	5.75	1.01	0.72
melanoma cell line:G-361	10465-106H6	16.02	9.50	5.97	1.90	0.81
meningioma cell line:HKBMM	10691-109F7	22.61	18.09	4.70	1.99	0.54
merkel cell carcinoma cell line:MKL-1	10843-111E6	44.06	13.22	6.17	3.52	3.52
merkel cell carcinoma cell line:MS-1	10844-111E7	16.85	7.00	2.85	1.81	1.04
mesenchymal precursor cell - adipose, donor1	11747-123G1	23.48	8.13	1.23	0.77	0.00
mesenchymal precursor cell - adipose, donor2	11748-123G2	21.45	7.45	2.73	1.27	0.55
mesenchymal precursor cell - adipose, donor3	11749-123G3	19.88	9.11	2.07	1.24	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	11.66	12.92	2.67	1.40	0.28
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	18.87	13.67	5.58	2.12	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	29.85	11.80	2.08	0.69	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	18.71	14.07	4.63	1.72	0.86
mesenchymal precursor cell - cardiac, donor2	11753-123G7	16.33	9.66	3.11	1.38	0.12
mesenchymal precursor cell - cardiac, donor3	11754-123G8	19.23	7.16	3.05	0.93	0.00
mesenchymal precursor cell - cardiac, donor4	11755-123G9	23.63	20.39	6.62	2.57	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	21.48	8.68	3.13	0.57	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	25.69	18.11	7.58	2.63	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	17.71	7.75	2.35	1.11	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	16.76	10.82	2.79	1.05	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	16.74	8.17	1.84	1.02	0.20
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	14.38	10.06	5.03	2.52	0.72
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	14.38	6.72	1.24	0.83	0.31
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	8.44	8.21	1.82	1.14	0.68
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	33.56	5.45	3.78	0.84	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	19.88	9.12	3.14	1.79	0.45
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	20.22	8.93	2.80	2.10	0.79
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	15.46	15.09	6.26	0.37	0.74
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	11.73	17.74	3.72	2.29	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	29.47	18.10	0.84	1.26	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	14.16	9.59	0.91	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	12.28	7.93	1.79	0.77	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	16.23	10.47	2.09	1.05	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	14.17	8.32	2.46	1.54	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	13.18	6.83	0.94	1.41	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	13.54	8.46	2.03	1.02	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	12.97	5.50	2.75	1.18	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	14.36	4.63	0.93	1.85	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	9.23	6.92	2.60	1.44	0.29
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	8.92	5.80	1.56	1.12	0.45
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	14.18	6.25	1.68	0.96	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	5.87	8.80	2.20	0.73	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	8.39	5.71	1.68	0.67	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	12.28	6.14	1.64	1.23	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	11.60	8.16	1.72	0.86	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	8.20	13.67	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	20.66	15.49	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	14.94	10.72	1.30	0.65	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	8.73	5.82	2.91	2.91	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	15.99	14.39	2.13	1.07	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	8.18	11.45	3.27	0.82	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	16.71	9.72	1.55	0.78	0.78
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	23.09	16.79	4.20	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	14.90	7.95	0.99	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	19.07	4.77	4.77	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	18.97	9.49	3.56	0.59	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	17.06	12.18	0.00	2.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	8.87	8.23	0.63	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	13.11	13.11	2.76	1.03	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	12.90	8.60	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	11.98	15.97	3.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	27.55	17.22	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	18.74	11.82	2.44	1.63	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	22.24	9.53	2.38	0.79	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	18.28	7.07	0.59	2.36	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	18.70	8.10	1.25	2.18	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	25.40	13.37	1.34	1.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	23.65	11.83	5.91	3.55	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	12.84	7.70	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	13.77	12.39	0.69	0.00	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	17.32	8.41	4.45	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	12.34	10.09	5.61	2.24	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	28.62	8.27	1.27	0.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	27.40	9.67	4.03	1.21	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	41.43	6.54	6.54	2.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	16.47	19.01	3.80	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	24.88	15.78	4.86	2.43	2.43
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	49.71	18.08	4.52	9.04	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	36.24	15.65	5.77	1.65	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	11.71	14.49	3.37	0.60	0.40
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	27.91	11.03	2.92	1.30	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	19.35	11.20	4.07	2.04	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	5.42	20.89	11.61	0.77	0.77
mesothelioma cell line:ACC-MESO-1	10493-107B7	53.63	46.07	18.43	1.42	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	24.33	14.13	4.63	2.09	0.46
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	42.74	21.37	4.27	8.55	4.27
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	21.58	14.59	5.45	5.96	1.54
mesothelioma cell line:Mero-25	10850-111F4	13.62	6.58	2.27	1.13	0.00
mesothelioma cell line:Mero-41	10851-111F5	18.82	8.80	2.20	1.22	0.24
mesothelioma cell line:Mero-48a	10852-111F6	23.03	12.40	7.31	0.89	0.22
mesothelioma cell line:Mero-82	10853-111F7	50.98	10.25	6.04	4.73	0.79
mesothelioma cell line:Mero-83	10854-111F8	22.81	9.02	3.74	3.40	0.34
mesothelioma cell line:Mero-84	10855-111F9	12.39	9.10	2.02	1.01	0.25
mesothelioma cell line:Mero-95	10856-111G1	16.56	7.87	4.55	3.52	0.62
mesothelioma cell line:NCI-H2052	10847-111F1	16.40	9.94	6.29	1.66	0.00
mesothelioma cell line:NCI-H226	10846-111E9	19.37	9.41	4.34	1.99	0.18
mesothelioma cell line:NCI-H2452	10848-111F2	23.74	10.25	3.07	3.59	1.02
mesothelioma cell line:NCI-H28	10845-111E8	26.97	10.18	3.31	6.11	2.04
mesothelioma cell line:No36	10857-111G2	13.70	7.18	0.65	2.28	0.65
mesothelioma cell line:ONE58	10858-111G3	17.07	25.47	8.40	1.90	0.54
migratory langerhans cells, donor1	11901-125F2	17.27	24.76	4.99	0.38	0.38
migratory langerhans cells, donor2	11902-125F3	12.46	19.66	2.56	0.85	0.73
migratory langerhans cells, donor3	11903-125F4	16.87	31.23	4.31	1.79	0.54
mixed mullerian tumor cell line:HTMMT	10689-109F5	44.73	13.06	5.55	2.94	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	26.28	5.93	2.97	1.06	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	19.12	37.55	10.60	0.46	0.46
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	43.77	20.17	27.78	2.28	0.38
myelodysplastic syndrome cell line:SKM-1	10772-110F7	24.21	18.85	5.73	3.33	1.85
myeloma cell line:PCM6	10474-106I6	21.15	14.23	3.56	0.79	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	15.22	11.16	3.04	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	14.71	6.47	3.92	2.35	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	12.03	20.06	4.35	1.45	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	11.33	18.31	3.75	1.54	0.37
nasal epithelial cells, donor2	12227-129F4	24.84	30.36	11.04	1.10	0.00
neuroblastoma cell line:CHP-134	10508-107D4	48.31	27.84	10.58	7.59	3.22
neuroblastoma cell line:NB-1	10539-107G8	25.07	46.77	8.61	2.99	1.31
neuroblastoma cell line:NBsusSR	10607-108F4	26.78	4.64	2.74	0.84	0.63
neuroblastoma cell line:NH-12	10555-107I6	52.74	17.33	2.80	8.94	2.42
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	30.84	17.08	3.80	4.74	2.37
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	32.15	23.76	4.28	2.38	1.27
neuroectodermal tumor cell line:TASK1	10774-110F9	21.33	10.06	3.42	2.82	0.81
neuroepithelioma cell line:SK-N-MC	10728-110A8	15.26	20.34	7.63	0.64	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	35.93	14.37	0.80	1.06	0.00
neutrophil PMN, donor1	12133-128D9	0.00	44.62	14.87	0.00	0.00
neutrophil PMN, donor2	12137-128E4	39.84	53.12	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	28.41	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	61.05	28.75	9.64	3.72	1.86
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	36.82	20.01	3.20	0.80	3.20
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	29.18	27.25	4.17	2.89	1.60
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	32.58	17.34	4.73	1.05	0.00
nucleus accumbens, adult, pool1	10037-101F1	13.22	24.84	11.53	3.37	1.03
occipital cortex - adult, donor10196	10172-103C1	28.85	43.27	16.48	0.00	2.06
occipital cortex, adult, donor10252	10163-103B1	36.23	39.45	9.66	4.03	1.07
occipital cortex, newborn, donor10223	10355-105E4	31.30	33.85	7.28	4.37	0.36
occipital lobe, adult, donor1	10076-102A4	22.04	59.56	12.86	2.62	2.36
occipital lobe, fetal, donor1	10073-102A1	39.91	80.24	11.59	3.86	1.72
occipital pole, adult, pool1	10036-101E9	9.54	18.61	7.02	1.73	0.47
olfactory region, adult	10195-103E6	27.32	23.12	9.74	2.48	0.96
optic nerve, donor1	10277-104E7	48.03	24.01	14.01	2.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	6.38	9.00	2.96	2.16	0.23
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	18.55	13.19	3.16	1.37	0.27
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	30.82	24.38	7.11	1.35	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	32.34	13.98	4.74	2.54	0.81
osteoclastoma cell line:Hs 706.T	10704-109H2	19.11	14.99	5.29	2.06	0.59
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	5.61	29.90	9.34	0.93	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	10.18	24.17	3.61	2.76	0.21
ovary, adult, pool1	10020-101D2	15.20	21.14	3.76	1.40	0.26
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	16.68	8.80	1.47	0.37	0.00
pancreas, adult, donor1	10049-101G4	36.68	32.92	6.58	1.88	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	32.43	29.63	5.87	2.80	1.12
papillary adenocarcinoma cell line:8505C	10437-106E5	38.84	18.40	4.77	4.43	1.53
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	14.24	10.60	5.30	3.48	0.17
paracentral gyrus, adult, pool1	10035-101E8	15.56	25.53	8.33	3.84	0.64
parietal cortex, adult, donor10258	10373-105G4	41.84	33.03	15.41	2.20	0.00
parietal lobe - adult, donor10196	10171-103B9	25.39	41.38	11.29	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	35.91	33.06	6.27	4.85	1.71
parietal lobe, adult, pool1	10034-101E7	11.72	25.91	8.28	3.70	0.70
parietal lobe, fetal, donor1	10072-101I9	61.10	48.49	7.76	1.94	1.94
parietal lobe, newborn, donor10223	10356-105E5	34.77	34.77	15.70	5.61	0.75
parotid gland, adult	10199-103F1	14.80	16.03	6.17	0.62	1.85
penis, adult	10200-103F2	41.89	29.00	6.45	2.15	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	16.55	14.13	2.79	0.37	0.19
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	37.88	21.56	6.99	3.21	0.44
pineal gland - adult, donor10196	10179-103C8	38.70	41.93	29.67	3.23	0.65
pineal gland, adult, donor10252	10160-103A7	31.98	56.26	25.47	4.15	1.18
pineal gland, adult, donor10258	10377-105G8	23.20	18.19	10.03	3.76	1.25
pituitary gland - adult, donor10196	10180-103C9	43.51	35.41	14.17	10.12	2.02
pituitary gland, adult, donor10252	10162-103A9	25.54	56.29	10.42	12.51	0.52
pituitary gland, adult, donor10258	10378-105G9	28.09	20.43	8.51	5.11	1.70
placenta, adult, pool1	10021-101D3	25.48	39.67	16.66	2.58	0.32
plasma cell leukemia cell line:ARH-77	10840-111E3	17.61	17.35	6.22	2.25	1.06
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	18.99	26.30	7.78	0.78	0.31
pons, adult, pool1	10033-101E6	11.27	15.58	4.91	3.01	1.12
postcentral gyrus, adult, pool1	10032-101E5	16.04	25.28	10.03	3.23	0.61
promyelocytes/myelocytes PMC, donor1	12132-128D8	0.00	14.64	0.00	2.09	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	16.52	16.52	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	11.74	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	21.70	13.69	5.54	1.89	0.29
prostate cancer cell line:PC-3	10439-106E7	21.42	10.35	6.35	0.73	0.00
prostate, adult, pool1	10022-101D4	16.23	27.57	4.08	4.26	0.27
putamen, adult, donor10196	10176-103C5	23.84	37.06	7.08	2.83	0.71
putamen, adult, donor10252	10152-102I8	21.57	60.78	11.76	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	30.60	17.48	5.46	2.19	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	15.70	21.99	9.91	0.97	0.00
putamen, newborn, donor10223	10365-105F5	50.23	50.23	14.99	11.24	1.50
rectal cancer cell line:TT1TKB	10469-106I1	44.51	43.64	16.29	2.62	0.00
rectum, fetal, donor1	10067-101I4	47.29	73.72	25.04	2.78	2.78
renal cell carcinoma cell line:OS-RC-2	10411-106B6	5.09	9.54	1.06	0.21	0.42
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	31.48	32.72	3.73	4.97	1.24
retina, adult, pool1	10030-101E3	16.10	20.28	5.07	1.89	0.00
retinoblastoma cell line:Y79	10475-106I7	44.43	14.29	7.27	5.46	3.38
rhabdomyosarcoma cell line:KYM-1	10787-110H4	23.61	12.91	2.21	1.23	0.25
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	30.93	13.22	4.22	1.41	0.84
sacrococcigeal teratoma cell line:HTST	10695-109G2	12.88	15.16	6.82	1.52	0.00
salivary acinar cells, donor1	11771-123I7	9.87	13.76	4.21	1.62	0.32
salivary acinar cells, donor2	11772-123I8	20.79	19.00	6.88	3.44	0.55
salivary acinar cells, donor3	11773-123I9	14.57	31.12	6.62	0.66	0.00
salivary gland, adult, pool1	10093-102C3	17.16	20.59	3.43	1.72	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	20.15	16.78	8.52	2.53	0.34
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	26.68	21.98	11.64	3.29	0.35
seminal vesicle, adult	10201-103F3	26.98	30.16	4.76	3.17	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	29.88	26.96	4.37	5.59	0.97
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	22.40	10.32	7.05	2.26	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	27.10	9.03	4.01	1.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	49.83	14.37	4.03	5.10	1.75
signet ring carcinoma cell line:Kato III	10436-106E4	26.20	20.01	6.63	1.33	0.33
signet ring carcinoma cell line:NUGC-4	10483-107A6	14.19	17.68	6.06	3.23	1.16
skeletal muscle - soleus muscle, donor1	10282-104F3	224.86	103.56	10.64	0.71	0.00
skeletal muscle, adult, pool1	10023-101D5	111.78	85.52	14.75	5.04	0.24
skeletal muscle, fetal, donor1	10066-101I3	19.10	28.14	3.02	1.01	0.00
skin, adult, donor1	10074-102A2	13.57	40.71	13.57	0.00	0.00
skin, fetal, donor1	10065-101I2	32.82	64.39	4.42	0.63	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	39.36	21.35	6.34	2.33	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	24.27	14.18	8.51	4.41	1.26
small cell lung carcinoma cell line:DMS 144	10841-111E4	36.62	31.42	5.98	2.70	0.96
small cell lung carcinoma cell line:LK-2	10541-107H1	40.05	24.39	11.70	4.94	1.81
small cell lung carcinoma cell line:NCI-H82	10842-111E5	41.50	25.09	7.72	6.92	2.09
small cell lung carcinoma cell line:WA-hT	10562-108A4	46.20	10.46	6.54	2.40	1.31
small intestine, adult, pool1	10024-101D6	17.68	33.68	8.24	1.91	0.72
small intestine, fetal, donor1	10064-101I1	26.78	23.59	8.35	2.21	0.25
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	24.11	12.82	3.59	2.56	1.03
smooth muscle, adult, pool1	10048-101G3	19.38	36.18	3.88	1.81	0.26
somatostatinoma cell line:QGP-1	10781-110G7	12.33	48.24	7.24	2.68	0.00
spinal cord - adult, donor10196	10181-103D1	23.63	36.93	7.57	2.06	0.69
spinal cord, adult, donor10252	10159-103A6	12.22	29.18	5.52	3.94	0.79
spinal cord, adult, donor10258	10369-105F9	23.52	23.52	4.15	5.53	0.00
spinal cord, fetal, donor1	10056-101H2	23.17	60.37	5.49	2.44	0.61
spinal cord, newborn, donor10223	10359-105E8	19.75	35.36	5.51	3.21	2.30
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	21.21	24.49	3.88	1.64	0.00
spleen, adult, pool1	10025-101D7	13.22	11.23	3.19	1.87	0.33
spleen, fetal, pool1	10044-101F8	13.11	30.19	5.48	2.70	0.95
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	11.49	7.04	3.42	1.76	0.72
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	27.72	18.61	6.27	1.33	0.76
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	29.35	26.56	10.13	1.40	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	19.94	30.88	7.43	0.39	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	35.12	37.59	9.79	2.25	0.56
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	15.67	7.20	2.12	2.12	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	5.08	9.73	3.81	0.85	0.42
stomach, fetal, donor1	10062-101H8	42.72	28.84	10.68	2.14	0.00
submaxillary gland, adult	10202-103F4	15.38	24.50	1.14	3.99	0.57
substantia nigra - adult, donor10196	10178-103C7	542.74	162.82	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	28.04	22.02	1.87	4.57	0.83
substantia nigra, adult, donor10258	10371-105G2	27.41	20.69	9.83	3.10	1.03
substantia nigra, newborn, donor10223	10358-105E7	19.08	26.85	3.53	2.83	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	33.47	15.59	5.96	0.23	0.92
temporal lobe, adult, pool1	10031-101E4	12.46	24.67	6.95	2.37	1.19
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	44.87	66.95	11.40	3.56	1.42
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	37.36	33.40	5.71	3.08	3.08
tenocyte, donor1	11763-123H8	28.63	17.11	2.44	2.09	0.35
tenocyte, donor2	11765-123I1	40.82	23.27	6.49	3.05	0.00
tenocyte, donor3	11768-123I4	32.99	13.34	4.08	1.85	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	45.72	12.58	7.65	3.91	1.02
teratocarcinoma cell line:NCR-G1	10798-110I6	23.74	8.48	1.85	3.24	0.77
teratocarcinoma cell line:PA-1	10807-111A6	25.57	9.76	2.94	3.25	1.08
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	29.07	19.42	6.09	3.68	1.40
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	18.91	10.97	1.51	5.67	0.38
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	40.24	24.10	10.25	5.56	0.65
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	16.61	8.79	2.28	3.26	0.65
testis, adult, pool1	10026-101D8	30.28	22.55	9.88	3.01	0.54
testis, adult, pool2	10096-102C6	79.84	20.75	10.37	4.06	2.71
thalamus - adult, donor10196	10168-103B6	40.85	37.54	11.04	3.31	1.10
thalamus, adult, donor10252	10154-103A1	24.38	24.22	1.56	5.31	0.78
thalamus, adult, donor10258, tech_rep1	10370-105G1	47.73	12.32	3.08	1.54	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	19.43	18.12	5.43	1.48	0.33
thalamus, newborn, donor10223	10366-105F6	30.49	35.09	8.63	1.73	0.00
throat, adult	10209-103G2	61.92	28.21	13.48	1.75	1.00
throat, fetal, donor1	10061-101H7	44.18	44.49	9.45	1.52	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	30.21	14.90	2.38	0.99	0.99
thymus, adult, pool1	10027-101D9	8.65	27.84	8.55	1.39	0.70
thymus, fetal, pool1	10043-101F7	16.00	38.03	11.64	4.26	1.14
thyroid carcinoma cell line:KHM-5M	10776-110G2	27.92	21.14	7.18	3.19	0.53
thyroid carcinoma cell line:TCO-1	10783-110G9	33.94	29.47	8.10	2.79	1.12
thyroid, adult, pool1	10028-101E1	20.72	35.09	5.69	5.97	0.65
thyroid, fetal, donor1	10060-101H6	44.03	34.80	8.17	0.53	0.79
tongue epidermis (fungiform papillae), donor1	10288-104F9	64.67	126.26	3.08	6.16	0.00
tongue, adult	10203-103F5	57.21	30.70	8.37	2.09	0.00
tongue, fetal, donor1	10059-101H5	107.59	63.45	25.22	2.76	0.39
tonsil, adult, pool1	10047-101G2	9.62	27.25	4.61	2.70	0.70
trachea, adult, pool1	10029-101E2	11.12	29.53	5.48	2.54	0.57
trachea, fetal, donor1	10058-101H4	50.39	52.32	11.54	1.92	0.38
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	24.80	14.53	6.38	0.35	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	14.39	11.45	4.96	3.44	1.22
transitional-cell carcinoma cell line:JMSU1	10492-107B6	45.28	33.69	8.62	5.33	1.88
tridermal teratoma cell line:HGRT	10694-109G1	19.03	36.15	7.61	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	17.86	27.00	3.89	1.10	0.25
umbilical cord, fetal, donor1	10057-101H3	33.38	27.12	10.43	0.00	2.09
uterus, adult, pool1	10100-102D1	25.59	30.88	6.14	2.90	0.51
uterus, fetal, donor1	10055-101H1	44.03	42.49	5.63	3.07	1.02
vagina, adult	10204-103F6	15.51	32.31	6.46	11.63	0.00
vein, adult	10191-103E2	13.59	23.67	2.41	2.41	0.22
xeroderma pigentosum b cell line:XPL 17	10563-108A5	19.23	10.95	5.34	3.20	0.27